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ABSTRACT
ROLE OF MOLECULAR CHAPERONES IN
G PROTEIN β5-REGULATOR OF G PROTEIN SIGNALING DIMER
ASSEMBLY AND G PROTEIN βγ DIMER SPECIFICITY

Alyson C. Howlett
Department of Chemistry and Biochemistry
Doctor of Philosophy

In order for G protein signaling to occur, the G protein heterotrimer must be
assembled from its nascent polypeptides. The most difficult step in this process is the
formation of the Gβγ dimer from the free subunits since both are unstable in the
absence of the other. Recent studies have shown that phosducin-like protein (PhLP1)
works as a co-chaperone with the cytosolic chaperonin complex (CCT) to fold Gβ
and mediate its interaction with Gγ. However, these studies did not address questions
concerning the scope of PhLP1 and CCT-mediated Gβγ assembly, which are
important questions given that there are four Gβs that form various dimers with 12
Gγs and a 5th Gβ that dimerizes with the four regulator of G protein signaling (RGS)
proteins of the R7 family. The data presented in Chapter 2 shows that PhLP1 plays a
vital role in the assembly of Gγ2 with all four Gβ1-4 subunits and in the assembly of
Gβ2 with all twelve Gγ subunits, without affecting the specificity of the Gβγ

interactions. The results of Chapter 3 show that Gβ5-RGS7 assembly is dependent on
CCT and PhLP1, but the apparent mechanism is different from that of Gβγ. PhLP1
seems to stabilize the interaction of Gβ5 with CCT until Gβ5 is folded, after which it
is released to allow Gβ5 to interact with RGS7. These findings point to a general role
for PhLP1 in the assembly of all Gβγ combinations, and suggest a CCT-dependent
mechanism for Gβ5-RGS7 assembly that utilizes the co-chaperone activity of PhLP1
in a unique way.
Chapter 4 discusses PhLP2, a recently discovered essential protein, and
member of the Pdc family that does not play a role in G protein signaling. Several
studies have indicated that PhLP2 acts as a co-chaperone with CCT in the folding of
actin, tubulin, and several cell cycle and pro-apoptotic proteins. In a proteomics
screen for PhLP2A interacting partners, α-tubulin, 14-3-3, elongation factor 1α, and
ribosomal protein L3 were found. Further proteomics studies indicated that PhLP2A
is a phosphoprotein that is phosphorylated by CK2 at threonines 47 and 52.
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CHAPTER 1 INTRODUCTION:
FUNCTION OF PHOSDUCIN-LIKE PROTEINS IN G PROTEIN
SIGNALING AND CHAPERONE-ASSISTED PROTEIN FOLDING

Summary
Members of the phosducin (Pdc) gene family were initially proposed to act as
down-regulators of G protein signaling by binding G protein βγ dimers (Gβγ) and
inhibiting their ability to interact with G protein α subunits (Gα) and effectors.
However, recent findings have over-turned this hypothesis by showing that most
members of the phosducin family act as co-chaperones with the cytosolic chaperonin
complex (CCT) to assist in the folding of a variety of proteins from their nascent
polypeptides. In fact, rather than inhibiting G protein pathways, phosducin-like
protein 1 (PhLP1) has been shown to be essential for G protein signaling by
catalyzing the folding and assembly of the Gβγ dimer. PhLP2 and PhLP3 have no
role in G protein signaling, but they appear to assist in the folding of proteins
essential in regulating cell cycle progression as well as actin and tubulin. Phosducin
itself is the only family member that does not participate with CCT in protein folding,
but it is believed to have a specific role in visual signal transduction to chaperone Gβγ
subunits as they translocate to and from the outer and inner segments of
photoreceptor cells during light-adaptation.
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Introduction
Eukaryotic cells use G protein signaling systems to mediate a wide array of
hormonal, neuronal and sensory signals that control numerous physiological
processes ranging from cardiac rhythm (1) to psychological behavior (2) to vision (3).
The importance of G protein signaling to cellular physiology is evidenced by the
large number of genes encoding GPCRs (~800 in humans (4)) and the myriad
diseases linked to malfunctions in G protein signaling (5). In fact, more than half of
all currently prescribed pharmaceuticals target GPCRs and other G protein pathway
components (6). Consequently, the mechanisms by which G protein signals are
propagated has been described in molecular detail (7). Signaling is initiated by the
binding of a ligand to the extracellular face of a GPCR, resulting in a change in the
packing of the seven transmembrane α-helices found in all GPCRs. This
conformational change activates the G protein on the intracellular surface of the
receptor by initiating an exchange of GDP for GTP on the G protein α subunit (Gα).
GTP binding causes Gα to dissociate from the G protein βγ subunit complex (Gβγ).
Both Gα-GTP and Gβγ control the activity of effector enzymes such as adenylyl
cyclase, cGMP phosphodiesterase, phospholipase Cβ, phosphatidylinositol-3-kinase,
Rho guanine nucleotide exchange factors, as well as K+ and Ca2+ ion channels. These
effectors regulate the intracellular concentration of second messengers (cyclic
nucleotides, inositol phosphates and Ca2+), the actin cytoskeleton (via Rho-GTP) and
the plasma membrane electrical potential (via K+ channels), thereby orchestrating the
cellular response to the stimulus.
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Controlling such
responses is vital to the cell.
Hence, G protein pathways are
exquisitely regulated and
regulatory targets are found at
multiple levels within the
cascade. At the level of the
GPCR, the ability of agonistbound receptors to activate G
proteins is blocked by
phosphorylation, arrestin
binding and internalization (2).
Interestingly, this deactivation
step with respect to the G
protein results in initiation of a
β-arrestin signaling pathway
that leads to activation of
mitogen-activated protein kinase
(MAPK) cascades (9). At the

Figure 1-1. Overview of G protein
signaling.
Once a ligand binds and activates a GPCR, the
GPCR acts as a guanine-nucleotide exchange
factor (GEF) for Gα which exchanges GDP for
GTP. GTP-bound Gα dissociates from Gβγ and
each moiety is free to bind and control the activity
of effector enzymes and ion channels. RGS
proteins act as GTPase accelerating proteins
(GAPs) to greatly accelerate Gα-GTP hydrolysis
back to Gα-GDP which associates with Gβγ.
Gαβγ can again bind to a GPCR, and if the GPCR
is active, undergo another round of signaling.
Reprinted by permission from Macmillan
Publishers Ltd: [Nat Rev Drug Discov], (8)
copyright (2002). http://www.nature.com

level of Gα, the lifetime of many Gα-GTP isoforms is decreased by acceleration of
GTP hydrolysis by regulators of G protein signaling (RGS) proteins and certain
effectors such as phospholipase Cβ (10). These GTPase accelerating proteins (GAPs)
play a vital role in determining the lifetime of the G protein signal (11). At the level
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of Gβγ, the binding of Pdc (12-15) and PhLP1 (16, 17) to Gβγ has been proposed to
control the amount of Gβγ available for interaction with effectors or with Gα-GDP.
However, this Gβγ sequestration model for Pdc and PhLP1 function has been brought
into serious question by recent findings (18-20). This introductory chapter will focus
on current understanding of the role of PhLP1 in Gβγ signaling and on the possible
functions of the other Pdc family members, PhLP2 and PhLP3.
The Pdc protein family appears to have ancient origins in that its members are
widely expressed in organisms varying from yeast to plants to man. The family can
be divided into three subgroups (21). Subgroup I includes the initial members of the
family, Pdc and PhLP1, which have been shown to bind Gβγ subunits with high
affinity (13, 22, 23). Pdc expression is very restricted, being found at significant
levels in only the photoreceptor cells of the retina and in the pineal gland (13, 24).
This expression pattern suggests a specific role for Pdc in light signaling. In contrast,
PhLP1 is broadly expressed in most tissues and cell types (25, 26), indicating a more
general function. Subgroup II consists of two recently discovered proteins in humans,
identified as PhLP2A and PhLP2B (21, 27, 28). The yeast ortholog of PhLP2 lacks
Gβγ binding ability, but is essential for cell growth in both the yeast Saccharomyces
cerevisiae (29) and the soil amoeba Dictyostelium discoideum (21), indicating a vital
function that is independent of G protein signaling. Subgroup III consists of a single
protein, designated PhLP3 (21). Again, the yeast ortholog of PhLP3 binds Gβγ
poorly (29), but its genetic deletion has no obvious phenotype in yeast (29) or
Dictyostelium (21). Closer analyses suggest that PhLP3 may participate in actin and
β-tubulin folding (30, 31). At first glance, these data portray the Pdc protein family
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Figure 1-2. The Pdc family phylogenetic tree.
The phosducin family contains three subfamilies. Protein sequences of 33 phosducin
homologues were obtained from different organisms. These sequences were aligned then
used as input for the Phylip program to create the tree. The numbers indicate bootstrap
values. Reprinted by permission from Macmillan Publishers Ltd: [EMBO J], (21)
copyright 2003. http://www.nature.com/emboj

as one with just a few members whose physiological roles are very diverse, having
apparently no single unifying cellular function. However, a common theme appears
to be emerging from recent findings which indicate that PhLPs 1-3 may all act as cochaperones in protein folding while Pdc may have a unique role in Gβγ signaling in
photoreceptor cells.
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The Physiological Function of PhLP1
Initial hypothesis — PhLP1 as a general inhibitor of G protein signaling
A close homolog of Pdc was discovered in a screen for genes whose
expression was induced by ethanol in neuronal cell cultures (25). This protein
displayed 65% sequence homology to Pdc and was consequently given the name of
phosducin-like protein (PhLP) (25). Pdc and PhLP make up subgroup I of the Pdc
protein family (21), and therefore PhLP will be referred to here as PhLP1 to
distinguish it from subgroup II and III family members. PhLP1 contains an 11 amino
acid sequence corresponding to Helix 1 of Pdc that is perfectly conserved (25). In
Pdc, this sequence of Helix 1 is a major site of interaction with Gtβγ (32).
Accordingly, PhLP1 was shown to bind Gβγ with similar affinity to Pdc (22) and to
block interactions of Gβγ with Gα and GRK2 in vitro (23, 33). As with Pdc, overexpression of PhLP1 inhibited G protein signaling (17), but unlike Pdc, PhLP1
displayed a broad expression pattern, being found in significant levels in most tissues
(25, 26, 34). These findings led to the hypothesis that it was PhLP1, and not Pdc, that
was the general down-regulator of G protein signaling through Gβγ sequestration.
Since these initial observations, several inconsistencies with a PhLP1mediated Gβγ sequestration hypothesis have been observed. First, the expression
levels of PhLP1 were significantly less than those of Gβγ (26) and had to be increased
to well above endogenous levels to begin to inhibit G protein signaling (17), raising
questions about the ability of endogenous PhLP1 to sequester much of the Gβγ pool
in the cell. This moderate expression level of PhLP1 is in contrast to the high
expression level of Pdc in photoreceptors, which matches that of Gβγ (20, 35) and
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provides sufficient Pdc to bind a large fraction of the Gβγ to exert a major effect on
its subcellular localization and signaling. Second, PhLP1 binding to Gβγ was not
regulated by phosphorylation (35, 36), suggesting that the interaction is more
constitutive in nature and less dependent on a phosphorylation-dependent feedback
loop like that of Pdc. Third, deletion of the phlp1 gene in the chestnut blight fungus
Cryphonectria parasitica (37) and in Dictyostelium discoideum (21) yielded the same
phenotypes as deletion of the Gβ gene, the opposite result of that expected if PhLP1
where a negative regulator of G protein signaling. Moreover, G protein signaling in
Dictyostelium was abolished by the deletion of phlp1, confirming a requirement for
PhLP1 in G protein function (21). Fourth, antisense oligonucleotide-mediated
knockdown of PhLP1 in mouse brain significantly prolonged the period of
desensitization induced by both acute and chronic expose to morphine (34), again
suggesting that PhLP1 was not an inhibitor of G protein signaling but rather a
promoter of both short and long-term responses to agonists. These inconsistencies
raised doubts about the sequestration hypothesis and led to the search for other
possible functions of PhLP1.
Overturning the paradigm — PhLP1 as an essential co-chaperone in Gβγ assembly
Clues about other functions of PhLP1 came from a proteomics screen for
PhLP1 binding partners in which a high affinity interaction of PhLP1 with the
cytosolic chaperonin complex (CCT) was discovered (38). This interaction was later
confirmed in yeast protein–protein interaction screens (39, 40). Interestingly, unlike
PhLP1, Pdc does not share the ability to bind CCT (38). CCT is an essential
chaperone of protein folding found in the cytosol of eukaryotic cells (41, 42). It
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consists of eight different, but related, subunits of ~60 kDa packed together to form a
ring structure (43). Two identical rings stack on top of each other to form the holoCCT complex of sixteen subunits (43). Nascent polypeptides and denatured proteins
associate in a large cavity formed in the center of each eight-membered ring (43).
Amino acid residues within the ring make contacts with the unfolded protein and
decrease the activation energy required to form the three-dimensional structure of the
native protein (44). Each CCT subunit binds ATP and uses the energy of ATP
hydrolysis to drive the folding process (45, 46). Actin and tubulin are major cellular
proteins that require CCT to fold, but other substrates have been described. In fact, it
has been estimated that 5-15% of cellular proteins are assisted in their folding by
CCT (47, 48). Among the known substrates of CCT are Gα (49) and several proteins
with seven β-propeller WD40 structures similar to that of Gβ (42, 50, 51). PhLP1 did
not bind CCT as a folding substrate, but rather it interacted in its native form,
suggesting a regulatory role for PhLP1 in CCT-dependent folding (38).
Important insight into the function of the PhLP1-CCT interaction has come
from the structure of the complex determined by cryo-electron microscopy (cryo-EM)
(52). Unlike folding substrates such as actin and tubulin which bind CCT within the
folding cavity, PhLP1 bound above the cavity, making contacts with only the tips of
the apical domains of the CCT subunits. PhLP1 spanned the folding cavity and
constricted the apical domains, effectively occluding the cavity. In many respects,
this structure is similar to that of CCT bound to prefoldin, a co-chaperone that
delivers actin and tubulin to CCT for folding (53). These substrates occupy the
folding cavity while prefoldin sits above the cavity with protrusions into the cavity
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(53). Together, these observations suggested that PhLP1 may act as a co-chaperone
for the folding of Gβ subunits by stabilizing an interaction between Gβ, Gγ and CCT
until the Gβγ reaches its native state. This idea was consistent with the observation
that when phlp1 was deleted in Dictyostelium, Gβ and Gγ no longer associated with
the plasma membrane, but exhibited a cytosolic localization that would be expected if
the subunits did not associate (21).

Figure 1-3. Cryo-EM structures of the PhLP1-CCT and apo-CCT complexes.
A. Top view of the PhLP1-CCT complex made by cryo-EM and 3-D reconstruction. B.
Side view of the PhLP1-CCT complex. C. Side view of apo-CCT. Reproduced with
permission from Proceedings of the National Academy of Sciences USA, (52)
copyright 2004. http://www.pnas.org

These findings set the stage for studies that directly measured the role for
PhLP1 and CCT in the folding and assembly of Gβγ (18, 19, 36, 54, 55). In one such
study, siRNA-mediated depletion of PhLP1 in mammalian cells resulted in a
significant decrease in Gβ1 expression that led to a corresponding decrease in G
protein signaling without affecting Gβ1 mRNA levels (19). Pulse-chase experiments
measuring Gβ1γ2 assembly in these cells showed that the rate of assembly decreased
by five-fold when the cells were depleted of 90% of their PhLP1 and increased by
four-fold when PhLP1 was over-expressed (19). These results demonstrated that the
decrease in Gβ1 expression and G protein signaling upon PhLP1 depletion was
9

caused by an inability to form Gβγ dimers. Similar data were obtained when the
PhLP1 gene was deleted in Dictyostelium; cells were completely devoid of Gβγ
dimers (54). CCT was also strongly implicated in the Gβγ assembly process by the
observation that nascent Gβs bound to CCT in translation assays in vitro (55).
Moreover, addition of Gγ subunits significantly decreased Gβ binding to CCT while
increasing Gβ binding to Gγ in an ATP-dependent manner (55). Together, these
observations indicated that PhLP1 and CCT were somehow acting as co-chaperones
in the folding and assembly of the Gβγ dimer.
In order to catalyze Gβγ dimer formation, PhLP1 must be phosphorylated by
the protein kinase CK2 within a cluster of three consecutive serines at residues 18-20
(S18-20) (19). Initially, it was reported that PhLP1 was phosphorylated by CK2
within the S18-20 cluster and that an S18-20A alanine substitution variant was more
effective at inhibiting Gβγ signaling than wild-type PhLP1 (56). However, it was
unclear why the PhLP1 S18-20A variant was a better inhibitor given that CK2
phosphorylation of PhLP1 did not change its binding affinity for Gβγ (36).
Subsequently, the PhLP1 S18-20A variant was shown to block Gβγ assembly in a
striking manner (19). Over-expression of PhLP1 S18-20A in HEK-293 cells
decreased the rate of assembly by 15-fold compared to wildtype PhLP1 and by 4-fold
compared to an empty vector control (19). Thus, not only did PhLP1 S18-20A not
support Gβγ dimer formation, it was also able to block the ability of endogenous
PhLP1 to catalyze assembly in a dominant negative manner. Measuring the effects of
various serine to alanine substitutions within the S18-20 sequence on the rate of Gβγ
assembly led to the conclusion that at least two of the three serines must be
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phosphorylated in order for PhLP1 to effectively support assembly, with S20
phosphorylation being the most important (36).
A useful tool in understanding PhLP1-mediated Gβγ assembly was discovered
when an N-terminal 75 amino acids truncation of PhLP1 (PhLP1 Δ1-75) was found to
be an even more effective dominant negative inhibitor than PhLP1 S18-20A (19).
Over-expression of PhLP1 Δ1-75 completely blocks the Gβγ assembly process in
HEK-293 cells (19). This variant lacks both the S18-20 phosphorylation site as well
as the conserved Gβγ binding region corresponding to Helix 1 of Pdc. As a result,
PhLP1 Δ1-75 could not be phosphorylated and bound Gβγ poorly, yet it maintained
its full CCT binding capacity (19). Interestingly, the PhLP1 Δ1-75 variant is very
similar to a naturally occurring PhLP1 truncation (designated PhLP1s) that is missing
the N-terminal 83 amino acids due to alternative mRNA splicing (25, 56). When
over-expressed, PhLP1s blocked Gβ and Gγ expression and strongly inhibited Gβγ
signaling (18, 56), as would be predicted by the effects of PhLP1 Δ1-75 on Gβγ
assembly.
The data presented thus far establish the need for PhLP1 and CCT in Gβγ
dimer formation, but they give little insight into the mechanism by which this process
occurs. The cryo-EM structure of PhLP1-CCT suggested that PhLP1 might stabilize
the binding of nascent Gβ to CCT by forming a ternary complex with Gβ positioned
in the CCT folding cavity and PhLP1 sitting above the cavity (52). Contrary to this
prediction, overexpression of PhLP1 was found not to increase but rather to decrease
the binding of Gβ to CCT (36). However, overexpression of the PhLP1 S18-20A and
Δ1-75 variants resulted in a large increase in Gβ binding to CCT, indicating that
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when PhLP1 is not phosphorylated, a stable PhLP1-Gβ-CCT ternary complex is
formed (36). Thus, it appears that PhLP1 phosphorylation destabilizes the ternary
complex. This idea is supported by the fact that the rate of release of nascent Gβ
from CCT was accelerated by PhLP1 but was inhibited by PhLP1 S18-20A (36). The
inability of PhLP1 S18-20 and Δ1-75 variants to release Gβ from CCT explains their
dominant negative effect on Gβγ assembly. These variants would compete with
endogenous PhLP1 for binding the Gβ-CCT complex by forming stable ternary
complexes that would not release Gβ.
The mechanism of Gβ release may involve steric repulsion between the
phosphates in the S18-20 cluster and negatively charged residues on the apical
domains of CCT. This repulsion would cause the dissociation of a phosphorylated
PhLP-Gβ intermediate that would subsequently associate with Gγ. Support for a
PhLP-Gβ intermediate comes from several observations. First, complexes of nascent
PhLP1 and Gβ were found that do not contain Gγ (19). Second, Gγ did not accelerate
the rate of Gβ release from CCT beyond that observed in the presence of PhLP1 (36).
Third, Gγ did not interact with CCT either directly or in a complex with Gβ (36, 55).
Interestingly, a separate chaperone for Gγ has very recently been reported to be
DRiP78, an ER membrane protein of the Hsp40 chaperone family that participates in
GPCR trafficking (57). PhLP1 was also shown to interact with DRiP78, suggesting
that the PhLP1-Gβ complex may interact with Gγ-bound DRiP78 to facilitate Gβγ
dimer formation (57). From these observations, a mechanistic model of Gβγ
assembly can be proposed as depicted in Fig. 1-4. PhLP1 plays a central role in this
model by releasing nascent Gβ from CCT in a PhLP1-Gβ complex that then picks up
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Figure 1-4. Model of PhLP1-mediated Gβγ dimer assembly.
Nascent Gβ binds CCT within the folding cavity and PhLP1 associates above Gβ, forming
a ternary complex. If PhLP1 is not phosphorylated within the S18-20 sequence by CK2,
the ternary complex is stable and inactive in Gβγ assembly. If PhLP1 is phosphorylated at
this site, then a PhLP1-Gβ complex is released from CCT and interacts with Gγ bound to
DriP78, forming the Gβγ dimer. PhLP1 is released when Gβγ associates with Gα and the
ER membrane, and the G protein heterotrimer is then trafficked to the plasma membrane.
PhLP1 is then free to catalyze another round of Gβγ assembly.

nascent Gγ from DRiP78 to form the Gβγ dimer at the ER membrane. Subsequent
association of Gα with Gβγ on the membrane would release PhLP1 for additional
rounds of dimer formation.

The Emerging Roles of Other Pdc Family Members
Other members of the Pdc family were first identified in a search for Pdc-like
proteins in yeast (29). They were originally named Plp1 and Plp2, but later

13

phylogenetic analysis placed Plp1 in subgroup III and Plp2 in subgroup II of the Pdc
family, so the current convention is to refer to group II subfamily members as PhLP2
and group III members as PhLP3 (21). There is a high degree of sequence homology
between all Pdc family members in the C-terminal ~150 amino acids (Fig. 1-5),
indicating that all probably retain the thioredoxin fold of the C-terminal domain of
Pdc. In contrast, their N-terminal regions differ significantly (21, 29). The Nterminal domains of Pdc and PhLP1 both contain a conserved 11-amino acid
sequence of Helix 1 which is imperative in binding Gβγ, while PhLP2 and PhLP3 do
not have this sequence and they bind Gβγ poorly (Fig. 1-5) (29). PhLPs 1-3 all
contain an acidic sequence in the loop between Helix 2 and 3 of the Pdc structure that
is not well conserved in Pdc (21). This acidic region has been shown to play an
important role in the binding of PhLP1 to CCT (19, 52), and accordingly, PhLPs 1-3
all bind CCT while Pdc does not (31, 38, 58). Apart from this loop and the Helix 3
region that follows, there is very little homology in the N-terminal domain between
Pdc subfamily members (21). PhLP2 and PhLP3 are believed to bind CCT in a
manner analogous to PhLP1, as native binding partners and regulators of CCT and
not as nascent folding substrates (31, 38, 58). These findings suggest that PhLP2 and
PhLP3 might function like PhLP1 as co-chaperones with CCT in protein folding.
PhLP2 — an essential gene involved in CCT-dependent protein folding
Phlp2 genes have been found in many eukaryotic genomes including human,
mouse, zebrafish, and fly and have been shown to have an essential function in D.
discoideum and S. cerevisiae (21, 29). Deletion of the phlp2 gene in yeast yielded
spore products that failed to grow (29), while disruption of phlp2 in Dictyostelium led
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Figure 1-5. Sequence alignment of Pdc family members.
Sequences of the five human Pdc family members were aligned using CLUSTAL W.
Regions of homology between sequences are shaded and gaps are represented by dashes.
The structural division between the N-terminal domain and the thioredoxin-like Cterminal domain is indicated by the arrow pointing downward, and the secondary
structural components of Pdc are indicated above the sequence (bar = helix, arrow = βsheet, line = loop, dashed line = unstructured region) (32). Sites of interaction of PhLP1
with CCT as determined by cryo-EM and mutagenesis are indicated below the sequence
(lined bars) (52). The S18-20 CK2 phosphorylation site of PhLP1 is in bold and
underlined as are the S54 CaMK and S73 PKA phosphorylation sites of Pdc.

to a decreasing growth rate and simultaneous collapse of the cell culture after 16–17
cell divisions (21). The essential function of PhLP2 appears to be separate and
unrelated to Gβγ signaling as indicated by the lack of effect of PhLP2 and PhLP3
over-expression or phlp3 deletion on the Gβγ-dependent mating pheromone response
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in yeast (29). Furthermore, yeast temperature sensitive phlp2 mutants show no
change in sensitivity of their pheromone response at restrictive temperatures (58). In
humans and mice there are two phlp2 genes designated as phlp2A and phlp2B (21).
These two genes share 57% sequence homology, but differ in expression patterns
(28). PhLP2A is a broadly-expressed cytosolic phosphoprotein (28), while PhLP2B
is only expressed in male and female germ cells undergoing meiotic maturation (27).
As a result of this limited expression in the mouse, PhLP2B was initially referred to
as mouse germ cell-specific phosducin-like protein (MgcPhLP) (27). Interestingly,
PhLP2B expression is able to rescue the lethal phenotype of yeast phlp2Δ, indicating
an evolutionarily-conserved function. Given their sequence similarity, shared CCT
binding capability and distinct expression patterns, it is believed that PhLP2A and
PhLP2B have similar, albeit tissue-specific, functions.
Analyses of temperature sensitive phlp2 mutants in yeast suggest a possible
role for PhLP2 in proper cell cycle progression and cytoskeletal function (58). A
screen to identify genes that partially rescued the lethal defects of phlp2 mutants at
restrictive temperatures revealed several promoters of the G1/S cell cycle transition
(58). In addition, temperature sensitive phlp2 mutants exhibited a delay in DNA
replication and impeded S-phase entry (58). Interestingly, temperature sensitive
mutants of cct subunits also displayed defects in cell cycle progression (50, 51),
suggesting a possible co-chaperone role of PhLP2 with CCT in the folding of
components essential in regulating cell cycle progression. The temperature sensitive
phlp2 mutants also harbored defects in cytoskeletal function. Growth at semipermissive temperatures was sensitive to the microfilament disrupting drug
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latrunculin and to a lesser extent, the microtubule disrupting drug benomyl (58).
Moreover, the mutants displayed significantly larger cell sizes and budding defects,
which also suggest actin or tubulin deficiencies (58). These results point to a role for
PhLP2 in the folding of actin and possibly tubulin by CCT. However, in vitro
experiments show that while human PhLP2A forms a ternary complex with CCT and
actin much like PhLP1, CCT and Gβ, this complex is inactive and actin folding is
inhibited by PhLP2A (58). This discrepancy between the in vivo phenotypes and the
in vitro results could be explained if PhLP2 were not directly required for actin
folding, but for the folding of actin-associated proteins necessary for cytoskeletal
function. Alternatively, necessary cofactors for PhLP2-mediated actin folding may
be missing in vitro. The cytoskeletal defects in phlp2 mutants are probably not
responsible for the observed cell cycle defects because genes that partially rescued the
cell cycle phenotype did not affect the cytoskeletal phenotype (58). Perhaps the best
explanation of the phlp2 temperature sensitive mutant results is that PhLP2
participates with CCT in the folding of several substrates important in cell cycle
control and cytoskeletal function (58).
Human PhLP2A has also been referred to as viral inhibitor of apoptosisassociated factor (VIAF) because of an interaction between PhLP2A and the
baculovirus Orgyia pseudotsugata inhibitor of apoptosis protein (Op-IAP) that was
discovered in a human B cell yeast two-hybrid screen (28). Further investigation
proved that PhLP2A does not serve as an antagonist to Op-IAP, but that PhLP2A is
ubiquitinated by Op-IAP (28). However, PhLP2A was shown to play an essential
role in the progression of apoptosis when siRNA knockdown of PhLP2A was found
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to completely inhibit the processing of caspase-3 following the initiation of Baxinduced programmed cell death (28). Given the apparent role of PhLP2A in CCTdependent protein folding, these results may best be explained by PhLP2-assisted
folding of one or more proapoptotic factors.
PhLP3 — a potential co-chaperone for β-tubulin and other CCT substrates
Despite the high degree of homology in their C-terminal domains and their
shared ability to bind CCT, PhLP3 has a physiological function distinct from PhLP2.
This conclusion stems from the very different phenotypes of phlp2 and phlp3
deletions in yeast and Dictyostelium. The phlp2 deletion in both organisms resulted
in a loss of viability whereas phlp3 deletion had no obvious effect (21, 29).
Moreover, PhLP3 over-expression did not rescue the lethality of phlp2 deletion (29).
Further genetic analyses have suggested a role for PhLP3 in β-tubulin folding. In
yeast, deletion of phlp3 protected cells against the toxic effects of excess free βtubulin, suggesting that PhLP3 is necessary for β-tubulin folding (30, 31). In C.
elegans, siRNA-mediated knockdown of PhLP3 resulted in defects in microtubule
architecture and aberrant cytokinesis, again pointing to a positive role of PhLP3 in
tubulin function (59). Interestingly, cryo-EM studies have demonstrated the
formation of a ternary complex between PhLP3, tubulin and CCT, indicating that
PhLP3 interacts directly with CCT to regulate β-tubulin folding (31). In contrast to
the positive role of PhLP3 predicted from the genetic studies, in vitro β-tubulin
folding assays showed significant inhibition by PhLP3 (31). This same discrepancy
between in vivo genetic phenotypes and in vitro folding measurements was observed
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with PhLP2 (58). Again, important co-factors for PhLP3-induced tubulin folding
may be missing in the in vitro assays.
PhLP3 also appears to regulate actin function. Genetic deletion of the pac10
subunit of prefoldin in yeast results in a marked decrease in F-actin in the cell, while
dual phlp3Δ and pac10Δ deletions restored F-actin to the same level as wild-type
(31). This finding suggests that PhLP3 may somehow down-regulate actin expression
or F-actin formation. In support of this finding, PhLP3 inhibits actin folding in in
vitro assays (31). However, the phlp3Δpac10Δ deletions greatly impaired a number
of actin dependent functions compared to pac10Δ alone or wild-type cells (31).
These data do not give a clear picture of the role of PhLP3 in actin function possibly
as a result of both direct effects on actin folding and indirect effects on actinassociated proteins. Nevertheless, it is clear that PhLP3 does work in concert with
prefoldin and CCT to regulate actin function.

Conclusion
The initial view of members of the Pdc gene family as downregulators of G
protein signaling through sequestration of Gβγ has been completely reversed in the
case of PhLP1, and shown to be irrelevant in the case of PhLPs 2 and 3. PhLPs 1-3
are now more accurately viewed as molecular co-chaperones with CCT in the folding
and assembly of different CCT substrates. PhLP1 is an essential component in the
assembly of Gβγ dimers, mediating the release of Gβ from CCT to interact with Gγ.
PhLP2 is involved with CCT in the folding of yet to be identified cell cycle regulators
as well as actin or actin-associated proteins and possibly tubulin. PhLP3 is important
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in CCT-dependent folding of β-tubulin and possibly actin. In this manner, PhLP
isoforms may broaden the range of substrates that are effectively folded by CCT by
each assisting a unique subset of substrates in the folding process.
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CHAPTER 2:
SPECIFICITY OF PHOSDUCIN-LIKE PROTEIN 1-MEDIATED
G PROTEIN βγ ASSEMBLY

Summary
In order for G protein signaling to occur, the G protein heterotrimer must be
assembled from its nascent polypeptides. The most difficult step in this process is the
formation of the Gβγ dimer from the free subunits since both are unstable in the
absence of the other. Recent studies have shown that phosducin-like protein (PhLP1)
works as a co-chaperone with the cytosolic chaperonin complex (CCT) to fold Gβ
and mediate its interaction with Gγ. However, these studies did not address questions
concerning the scope of PhLP1 and CCT-mediated Gβγ assembly, which are
important questions given that there are four Gβs that form various dimers with 12
Gγs and a fifth Gβ that dimerizes with the four regulator of G protein signaling (RGS)
proteins of the R7 family. This chapter shows that PhLP1 plays a vital role in the
assembly of Gγ2 with all four Gβ1-4 subunits and in the assembly of Gβ2 with all 12
Gγ subunits, without affecting the specificity of the Gβγ interactions. These findings
point to a general role for PhLP1 in the assembly of all Gβγ combinations.

Introduction
Eukaryotic cells utilize receptors coupled to heterotrimeric GTP-binding
proteins to mediate a vast array of responses ranging from nutrient-induced migration
of single-celled organisms to neurotransmitter-regulated neuronal activity in the
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human brain (60). Ligand binding to a GPCR initiates GTP exchange on the G
protein heterotrimer (composed of Gα, Gβ, and Gγ subunits), which in turn causes the
release of Gα-GTP from the Gβγ dimer (61-63). Both Gα-GTP and Gβγ propagate
and amplify the signal by interacting with effector enzymes and ion channels (7, 60).
The duration and amplitude of the signal is dictated by receptor phosphorylation
coupled with arrestin binding and internalization (64) and by regulators of G protein
signaling (RGS) proteins, which serve as GTPase activating proteins for the GTPbound Gα subunit (10, 65). The G protein signaling cycle is reset as the inactive
Gα−GDP reassembles with the Gβγ dimer and Gαβγ reassociates with the GPCR (7).
In order to fulfill its essential role in signaling, the G protein heterotrimer
must be assembled post-translationally from its nascent polypeptides. Significant
progress has been made recently regarding the mechanism by which this process
occurs. It has been clear for some time that the Gβγ dimer must assemble first,
followed by subsequent association of Gα with Gβγ (66). What has not been clear
was how Gβγ assembly would occur given the fact that neither Gβ nor Gγ is
structurally stable without the other. An important breakthrough was the finding that
PhLP1 functions as a co-chaperone with CCT in the folding of nascent Gβ and its
association with Gγ (18, 19, 36, 54, 55, 67). CCT is an important chaperone that
assists in the folding of actin, tubulin, and many other cytosolic proteins including
many β-propeller proteins like Gβ (42). PhLP1 has been known for some time to
interact with Gβγ and was initially believed to inhibit Gβγ function (17). However,
several recent studies have demonstrated that PhLP1 and CCT work together in a
highly orchestrated manner to form the Gβγ dimer (18, 19, 36, 54, 55, 67).
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Studies on the mechanism of PhLP1-mediated Gβγ assembly have focused on
the most common dimer Gβ1γ2 (18, 19, 36), leaving open questions about the role of
PhLP1 in the assembly of the other Gβγ combinations. These are important
considerations given that humans possess 5 Gβ genes and 12 Gγ genes with some
important splice variants (68, 69), resulting in more than 60 possible combinations of
Gβγ dimers. Gβs 1-4 share between 80-90% sequence identity and are broadly
expressed (68, 69). Gβ5, the more atypical isoform, shares only about 53% identity
with Gβ1, carries a longer N-terminal domain, and is only expressed in the central
nervous system and retina (70). The Gγ protein family is more heterogeneous than
the Gβ family. The sequence identity of the 12 Gγ isoforms extends from 10-70%
(71), and the Gγ family can be separated into 5 subfamilies (71-73). All Gγ proteins
carry C-terminal isoprenyl modifications which contribute to their association with
the cell membrane, GPCRs, Gαs, and effectors (66). Subfamily I Gγ isoforms are
post-translationally farnesylated while all others are geranylgeranylated (73, 74).
There is some inherent selectivity in the assembly of different Gβγ
combinations, but in general Gβs 1−4 can form dimers with most Gγ subunits (75).
The physiological purpose of this large number of Gβγ combinations has intrigued
researchers in the field for many years, and a large body of research indicates that
GPCRs and effectors couple to a preferred subset of Gβγ combinations based
somewhat on specific sequence complementarity, but even more so on cellular
expression patterns, subcellular localization, and post-translational modifications
(69). In contrast to Gβs 1-4, Gβ5 does not interact with Gγ subunits in vivo, but it
instead forms irreversible dimers with RGS proteins of the R7 family.
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It has been recently shown that all Gβ isoforms are able to interact with the
CCT complex, but to varying degrees (55). Gβ4 and Gβ1 bind CCT better than Gβ2
and Gβ3 while Gβ5 binds CCT poorly (55). These results suggest that Gβ1 and Gβ4
might be more dependent on PhLP1 than the other Gβs, given the co-chaperone role
of PhLP1 with CCT in Gβ1γ2 assembly. However, another report has indicated that
Gγ2 assembly with Gβ1 and Gβ2 is more PhLP1-dependent than with Gβ3 and Gβ4
(57). Thus, it is not clear from current information whether PhLP1 plays a general
role in Gβγ dimer formation or whether it specifically catalyzes assembly of only a
subset of these complexes. This report was designed to systematically address this
issue.

Experimental Procedures
Cell culture
HEK 293T cells were cultured in DMEM/F-12 (50/50 mix) growth media
containing L-glutamine and 15 mM HEPES supplemented with 10% fetal bovine
serum (Sigma-Aldrich). The cells were subcultured regularly to maintain growth, but
were not used beyond 25 passages.
Preparation of cDNA constructs
The pcDNA3.1 vectors containing N-terminally Flag-tagged human Gβs 1-4,
Gβ5short, and N-terminally HA-tagged Gγs 1-5 and 7-13 were obtained from the
Missouri University of Science and Technology cDNA Resource Center
(www.cdna.org). Wild type human PhLP1 and the PhLP1 Δ1-75 N-terminal
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truncation variant each with a 3′ c-myc and His6 tag were constructed in
pcDNA3.1/myc-His B vector using PCR as described (19, 76).
RNA interference experiments
Short interfering RNAs (siRNAs) were chemically synthesized (Dharmacon)
to target nucleotides 608-628 of human lamin A/C (19) and nucleotides 345-365 of
human PhLP1 (19). HEK 293T cells were grown in 12-well plates to 50-70%
confluency at which point they were transfected with siRNA at 100 nM final
concentration using Oligofectamine reagent (Invitrogen) as described previously (19).
Twenty four hours later, the cells were transfected with 0.5 μg each of Flag-Gβ or
HA-Gγ in pcDNA3.1(+) using Lipofectamine 2000 according to the manufacturer’s
protocol (Invitrogen). The cells were harvested for subsequent immunoprecipitation
experiments 72 hours later. Ten μg of cell lysate were immunoblotted with an antiPhLP1 antibody (35) to assess the percent PhLP1 knockdown.
Dominant interfering mutant experiments
HEK 293T cells were plated in 6-well plates and grown to 70-80%
confluency. The cells were then transfected with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Each well was transfected with 1.0 μg
of either the empty vector control, wild-type PhLP1-myc, or PhLP1 Δ1-75-myc along
with 1.0 μg each of the indicated Flag-Gβ and HA-Gγ cDNAs. The cells were
harvested for immunoprecipitation 48 hours after transfection.
Immunoprecipitation experiments
Transfected HEK 293T cells were washed with phosphate-buffered saline
(PBS) (Fisher) and solubilized in immunoprecipitation buffer (PBS pH 7.4, 2% NP-
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40 (Sigma), 0.6 mM PMSF, 6 μl/ml protease inhibitor cocktail per mL buffer (Sigma
P8340)). The lysates were passed through a 25-gauge needle 10 times and
centrifuged at maximum speed for 10-12 minutes at 4ºC in an Eppendorf microfuge.
The protein concentration for each sample was determined using the DC Protein
Assay Kit II (Bio-Rad) and equal amounts of protein were used in the subsequent
immunoprecipitations. Approximately 150 μg of total protein were used in
immunoprecipitations from cells in 12 well plates and 450 μg from cells in 6 well
plates. The clarified lysates were incubated for 30 minutes at 4°C with 2.5 μg antiFlag antibody (clone M2, Sigma), for lysates from 12-well plates or with 6.25 μg of
anti-Flag for lysates from 6-well plates. Next, 30 μl of a 50% slurry of Protein A/G
Plus agarose (Santa Cruz Biotechnology) was added, and the mixture was incubated
for 30 minutes at 4°C as described (19). The immunoprecipitated proteins were
solubilized in SDS sample buffer and resolved on a 10% Tris-Glycine-SDS gel or a
16.5% Tris-Tricine-SDS gel for Gγ. The proteins were transferred to nitrocellulose
and immunoblotted using an anti-Flag (clone M2, Sigma), anti-c-myc (BioMol), antiHA (Roche), or an anti-PhLP1 antibody (19). Immunoblots were incubated with the
appropriate anti-rabbit, anti-mouse, (Li-Cor Biosciences), or anti-rat (Rockland)
secondary antibody conjugated with an infrared dye. Blots were scanned using an
Odyssey Infrared Imaging System (Li-Cor Biosciences), and protein band intensities
were quantified using the Odyssey software. The data are presented as the mean
value +/- standard error from at least three experiments.
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Results
It has been shown that in order to mediate Gβγ assembly, PhLP1 must bind
Gβγ with high affinity (19, 36). As a first step toward determining the ability of
PhLP1 to catalyze Gβγ dimer formation with the five Gβ subunits, we measured the
interaction of PhLP1 with each Gβ subunit in complex with Gγ2 by coimmunoprecipitation. Equal amounts of myc-tagged PhLP1, Gγ2, and each Flagtagged Gβ 1-5 were over-expressed in HEK-293T cells. After incubation, cells were
harvested and immunoprecipitated with an anti-Flag antibody and immunoblotted
with anti-myc and anti-Flag antibodies. Protein band intensities were quantified and
the ratio of the PhLP1-myc band to each Flag-Gβ band was determined (Fig. 2-1A).
The data show that Gβs 1-4 all co-immunoprecipitated similar amounts of PhLP1
while Gβ5 co-immunoprecipitated significantly less, indicating that PhLP1 binds Gβ5
complexes with a lower affinity than it does Gβ1-4 complexes. All five Gβs
expressed equally well under these conditions, so the differences in binding can not
be attributed to different Gβ expression levels (Fig. 2-1A). These results suggest that
PhLP1 may be involved in Gβγ assembly of Gβ1-4, but perhaps not Gβ5.
To directly measure the contribution of PhLP1 to the assembly of the five Gβ
isoforms with Gγ, the effect of siRNA-mediated PhLP1 knockdown on Gβγ dimer
formation was measured by co-immunoprecipitation of Gγ2 with the Gβs. We chose
Gγ2 because it is a common isoform that associates to some extent with all Gβ
subunits in vitro (75). HEK 293T cells were treated with PhLP1 siRNA, a control
siRNA to lamin A/C or a mock treatment with no siRNA and then HA-Gγ2 and one
of the five Flag-tagged Gβ subunits were coexpressed. Cell lysates were
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Fig. 2-1. Effects of PhLP1
siRNA knockdown on the
assembly of all Gβ subunits
with Gγ2. HEK 293T cells were
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IP: Flag
PhLP1-myc
Flag-Gβ subunits
Gβ1

Gβ2

Gβ3

Gβ4

Gβ5

B.

IP: Flag
Flag-Gβ1
HA-Gγ2
Lysate
PhLP1

C.
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treated as follows: A) Cells were
transfected with PhLP1-myc, HAGγ2 and the indicated Flag-Gβ
cDNAs. After 48 hours, cells were
lysed, immunoprecipitated with an
anti-Flag antibody and
immunoblotted with anti-myc or
anti-Flag antibodies. The graph
represents the ratio of the PhLP1myc/Flag-Gβ band intensities for all
5 Gβs. Bars represent the average
± standard error from 3 separate
experiments. A representative blot
is shown below the graph. B, C)
Cells were treated with siRNA
against PhLP1, lamin A/C, or no
siRNA as indicated. Twenty-four
hours later, cells were transfected
with the indicated Flag-Gβ subunit
and HA-Gγ2 cDNAs. After 72
additional hours, cells were lysed,
immunoprecipitated with an antiFlag antibody and immunoblotted
with anti-Flag or anti-HA
antibodies. Bands were quantified
and expressed as a percentage of
the lamin A/C control for Gβ1γ2 in
(B) or as the ratio of HA-Gγ2/FlagGβ for all five Gβs in (C). PhLP1
knockdown was measured by
quantifying the PhLP1 band
intensity in immunoblots of 10 μg
of whole cell lysate. The average
PhLP1 knockdown was between
60-76% compared to the lamin A/C
control. Bars represent the average
± standard error from 3-5 separate
experiments. If no bar is shown,
then no complex was detected for
that particular Gβγ species. A
representative blot for Gβ1γ2 is
shown below the graph in (B).

immunoprecipitated with an anti-Flag antibody and the precipitate was
immunoblotted with anti-HA and anti-Flag antibodies to detect the amount of Gγ2
bound to each Gβ subunit. Fig. 2-1B shows the levels of PhLP1 in the cell extract
and the amounts of Flag-Gβ1 and HA-Gγ2 in the immunoprecipitate relative to the
lamin A/C siRNA control. A 75% knockdown of PhLP1 resulted in a 50% decrease
in Gβ1 and a striking 85% decrease in the co-immunoprecipitated Gγ2 compared to
the lamin A/C control. This pattern was consistent among all the Gβ subunits except
for Gβ5, which had no detectable Gγ2 bound under these conditions (Fig. 2-1C). To
more directly compare the effects of PhLP1 knockdown, the Gγ2/Gβ1-4 band
intensity ratios in the immunoprecipitates were determined for the three siRNA
conditions (Fig. 2-1C). In each case, much less Gγ2 was associated with Gβ when
PhLP1 was knocked down. The Gγ2/Gβ ratio decreased between 65-84% compared
to the lamin A/C control. These results indicate that PhLP1 does assist in the
formation of Gβγ complexes containing Gβs 1-4 with Gγ2.
To further examine the role of PhLP1 in Gβγ assembly with the different Gβ
subunits, an alternative method to block PhLP1 function was employed. It has been
shown previously that an N-terminally truncated PhLP1 variant in which the first 75
amino acids have been removed (PhLP1 Δ1-75) acts in a dominant interfering manner
to block Gβγ assembly by forming a stable PhLP1 Δ1-75-Gβ-CCT ternary complex
that does not release Gβ from CCT for association with Gγ (19, 36). Co-expression
of PhLP1 Δ1-75 with Flag-Gβ1 and HA-Gγ2 resulted in a dramatic reduction in the
amount of Gγ2 in the Gβ1 immunoprecipitate compared to wild-type PhLP1
(expressed at comparable levels) or to an empty vector control (Fig. 2-2A). This
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pattern was similar among Gβs 1-4. PhLP1 Δ1-75 decreased the Gγ2/Gβ ratios by
75-92% in the Gβ1-4 immunoprecipitates (Fig. 2-2B). For Gβ5, again very little Gγ2
was associated with it under these conditions. Interestingly, co-expression of
wildtype PhLP1 increased the amount of both Gβ and Gγ2 in the Flag-Gβ
immunoprecipitate by 30-50% for all five Gβ isoforms (Figs. 2-2A, 2-4A and 3-3B).
This observation is consistent with a PhLP1-mediated enhancement of Gβγ
formation, resulting in a stabilization of Gβ and Gγ expression. Together, these
findings confirm the siRNA knockdown results by showing that PhLP1 is important
in the assembly of each of the Gβs 1-4 with Gγ2.

A.

B.

IP: Flag
Flag-Gβ1
HA-Gγ2

Fig. 2-2. Effects of PhLP1 Δ1-75 expression on the assembly of all Gβ
subunits with Gγ2. HEK 293T cells were transfected with either wild-type PhLP1,
PhLP1 Δ1-75, or an empty vector control along with the indicated Flag-Gβ subunit and
HA-Gγ2 cDNAs. After 48 hours, cells were lysed, immunoprecipitated with an anti-Flag
antibody and immunoblotted with anti-Flag or anti-HA antibodies. Bands were
quantified and expressed as a percentage of the wild-type PhLP1 control for Gβ1γ2 in (A)
or as the ratio of HA-Gγ2/Flag-Gβ for all five Gβs in (B). Bars represent the average ±
standard error from 3-5 separate experiments. If no bar is shown, then no complex was
detected for that particular Gβγ species. A representative blot for Gβ1γ2 is shown below
the graph in (A).
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A second question regarding the scope of PhLP1-mediated Gβγ assembly is
whether all 12 Gγ subunits or just a subset require PhLP1 to associate with Gβ. To
address this question, the effects of siRNA-mediated PhLP1 knockdown and PhLP1
Δ1-75 over-expression on the association of the twelve Gγ subunits with Gβ2 were
measured. Gβ2 was chosen because it forms dimers with most Gγ isoforms, yet it
shows selectivity between the different Gγs (75). The siRNA knockdown
experiments followed the same format as those in Fig. 2-1. HEK 293T cells were
treated with PhLP1 siRNA, a control siRNA to lamin A/C or no siRNA and then coexpressed with Flag-Gβ2 and each of the 12 HA-tagged Gγ subunits. Cell lysates
were immunoprecipitated with an anti-Flag antibody and the precipitate was
immunoblotted with anti-HA and anti-Flag antibodies to detect the amount of each
Gγ subunit bound to Gβ2. Fig. 2-3A shows the levels of PhLP1 in the cell extract and
Flag-Gβ2 and HA-Gγ2 in the immunoprecipitate relative to the lamin A/C siRNA
control. The results were similar to the Gβ1γ2 experiment. The PhLP1 knockdown
was 80%, which resulted in a 30% decrease in Gβ2 and a 90% decrease in the coimmunoprecipitated Gγ2 compared to the lamin A/C control. This pattern was
consistent among all the Gβ2Gγ combinations that formed dimers. Gβ2 decreased by
20-50% while the co-immunoprecipitating Gγs decreased by 80-95% (data not
shown). Figure 2-3B compares the Gγ/Gβ2 band intensity ratios for the three siRNA
conditions. In each case, much less Gγ was associated with Gβ when PhLP1 was
knocked down. The Gγ/Gβ2 ratios decreased between 74-91% compared to the lamin
A/C control, except for Gγs 1, 11 and 13 which did not form dimers with Gβ2. These
results indicate that all Gβ2Gγ dimers depend upon PhLP1 for their assembly.
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IP: Flag
Flag-Gβ2
HA-Gγ2

PhLP1

Fig. 2-3. Effects of PhLP1 knockdown on the assembly of all Gγ subunits
with Gβ2. HEK 293T cells were treated with siRNA against PhLP1, lamin A/C, or no
siRNA as indicated. Twenty-four hours later, cells were transfected with the indicated
HA-Gγ subunit and Flag-Gβ2 cDNAs. After 72 additional hours, cells were lysed,
immunoprecipitated with an anti-Flag antibody and immunoblotted with anti-Flag or antiHA antibodies. Bands were quantified and expressed as a percentage of the lamin A/C
control for Gβ2γ2 in (A) or as the ratio of HA-Gγ/Flag-Gβ2 for all 12 Gγs in (B). PhLP1
knockdown was measured by quantifying the PhLP1 band intensity in immunoblots of 10
μg of whole cell lysate. The average PhLP1 knockdown was between 66-90% compared
to the lamin A/C control. Bars represent the average ± standard error from 3-14 separate
experiments. If no bar is shown, then no complex was detected for that particular Gβγ
species. A representative blot for Gβ2γ2 is shown below the graph in (A).

The dominant interference experiments with PhLP1 Δ1-75 followed a similar
pattern. Coexpression of PhLP1 Δ1-75 with Flag-Gβ2 and HA-Gγ2 resulted in a 50%
reduction in the amount of Gβ2 and a 95% reduction in the amount of Gγ2 in the Flag
immunoprecipitate when compared to the wild-type PhLP1 control (Fig. 2-4A).
Moreover, co-expression of wild-type PhLP1 increased both Gβ2 and Gγ2 levels by
50%, similarly to Gβ1γ2 (Fig. 2-2A). The effect of PhLP1 Δ1-75 on the Gγ/Gβ2 ratio
was the same for all the Gγs that formed dimers with Gβ2. The ratios were
drastically reduced by amounts ranging from 81-100%. Together with the PhLP1
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Fig. 2-4. Effects of PhLP1 Δ1-75 expression on the assembly of all Gγ
subunits with Gβ2. HEK 293T were transfected with either WT PhLP1, PhLP1 Δ175, or an empty vector control along with the indicated HA-Gγ subunit and Flag-Gβ2
cDNAs. After 48 hours, cells were lysed, immunoprecipitated with an anti-Flag antibody
and immunoblotted with anti-Flag or anti-HA antibodies. Bands were quantified and
expressed as a percentage of the wild-type PhLP1 control for Gβ2γ2 in (A) or as the
relative ratio of HA-Gγ/Flag-Gβ2 for all 12 Gγs in (B). Bars represent the average ±
standard error from 3-6 separate experiments. If no bar is shown, then no complex was
detected for that particular Gβγ species. A representative blot for Gβ2γ2 is shown below
the graph in (A).

knockdown data, these results clearly demonstrate that all Gγ subunits that interact
with Gβ2 require PhLP1 for dimer formation.
Another interesting observation that can be made from the data in Figures 23B and 2-4B concerns the effect of PhLP1 on the specificity of Gβ2γ dimer
formation. The Gγ subunits can be divided genetically into five subfamilies as shown
in the phylogenetic tree of Fig. 2-5A. Members of subfamily II form dimers with
Gβ2 readily, while members of the other subfamilies interact weakly with Gβ2 or not
at all (Fig. 2-5B and C). The order of dimer formation of the Gγ subfamilies with
Gβ2 is II > III > I, IV with no dimer formation found with subgroup V. This pattern
of Gβ2γ dimer specificity is similar to in vitro data reported previously (75).
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Importantly, PhLP1 does not appear to influence the specificity of Gβ2γ dimer
formation. The specificity pattern is the same no matter the level of PhLP1 activity.
For example, when PhLP1 is siRNA-depleted, Gβ2γ formation with Gγ subfamily II
is greater than with subfamilies III, I and IV by a similar factor as when PhLP1 is at
endogenous levels. Similarly, when PhLP1 function is blocked by the PhLP1 Δ1-75
variant, Gβ2γ formation with subgroup II is greater than the other subgroups by a
similar factor as when PhLP1 is over-expressed (Fig. 2-5B and C). Thus, it appears
that PhLP1 has no effect on which Gγ subunit will interact with Gβ2.

Discussion
Post-translational assembly of stable G protein heterotrimers is a fundamental
prerequisite for G protein signaling, yet the mechanism by which the assembly
process occurs had been an enigma for more than two decades since the G protein
heterotrimer was initially discovered. The most puzzling issue has been how the Gβ
and Gγ subunits could come together to form a stable dimer when the individual
polypeptides were structurally unstable. Recent studies have shed considerable light
on the assembly process and have outlined a mechanism by which CCT and PhLP1
work as co-chaperones to fold Gβ and present it to Gγ for dimerization to occur (18,
19, 36, 38, 52, 54, 55, 67). Gγ itself appears to be held by another chaperone DRiP78
(57) until it can interact with PhLP1-Gβ. Mechanistic studies have thus far focused
on the most common Gβ1γ2 dimer combination and have not addressed whether this
assembly mechanism was general to the many other Gβγ dimers, or specific to only a
subset. All the Gβ subunits have been recently shown to interact with CCT with Gβ5
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Fig. 2-5. Effects of PhLP1
knockdown on the specificity of
Gβ2 dimerization with Gγ
subfamilies. A) The phylogenetic

A.

relationship between human Gγ
subunits and RGS7 and 9 is
depicted. An unrooted dendrogram
was made using TreeView from a
Gγ family sequence alignment
created with ClustalX. The Gγ
family can be separated into 5
subfamilies as indicated. The scale
bar represents a substitution rate of
0.1 per amino acid. B) The Gγ/Gβ2
ratios within each Gγ subfamily
under the different siRNA
conditions from Fig. 3B were
averaged and plotted to show the
effects of PhLP1 knockdown on the
subfamily specificity of Gβ2Gγ
dimer formation. Error bars
represent the standard error of the
mean within each subfamily. C) A
similar average of the Gβ2Gγ ratios
for each subfamily under the
different PhLP1 over-expression
conditions from Fig. 4B was
calculated and plotted. If no bar is
shown, then no complex was
detected for that particular Gβγ
species.

B.

C.
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interacting weakly relative to the other Gβ subunits (55). The current study has
addressed the scope of PhLP1-mediated dimer assembly for many Gβγ combinations.
The results clearly show that PhLP1 is a general co-chaperone for Gβγ assembly. All
Gβ subunits required PhLP1 for association with Gγ2 (Figs. 2-1 and 2-2) and all Gγ
subunits that form dimers with Gβ2 required PhLP1 for association with Gβ2 (Figs.
2-3 and 2-4). It seems very likely that the other possible Gβγ dimer combinations
would also require PhLP1 for their assembly as well. Thus, it appears that all Gβγs
follow a similar mechanism of dimer formation.
Understanding the reasons why some Gβγ combinations form dimers and
others do not has been of interest in the field for some time (69). Apparent
differences in Gβγ specificity between in vitro assays and cell-based assays have
suggested that cellular factors that are involved in the assembly process such as
PhLP1 might influence Gβγ specificity (75). However, this does not appear to be the
case. As noted above, the specificity of Gβγ dimer formation was not changed by
increases or decreases in PhLP1 activity. Thus, it appears that PhLP1 is acting as a
true catalyst in Gβγ assembly by not influencing which Gβ can bind which Gγs but
simply facilitating the association of Gβγ combinations that are intrinsically stable.
In the case of the Gβ2γ combinations investigated here, dimer stability appears to be
determined by sequence specificity since Gγ binding segregated along subfamily lines
according to sequence homology (Fig. 2-5). Hence, the major factors that determine
Gβ2γ specificity appear to be limited to complementarity of the binding surfaces as
determined by specific amino acid interactions, the expression of the complementary
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Gβγ combinations in the same cell types, and the subcellular localization within the
cell (69).
It is interesting to note that inhibition of PhLP1 activity through siRNAmediated knockdown or over-expression of the PhLP1 Δ1-75 dominant negative
variant resulted in a surprisingly small decrease in Gβ expression (~ 50%), despite the
fact that very little of this residual Gβ was associated with Gγ (Figs. 2-1 through 2-4).
This finding indicates that Gβ can exist in the cell unassociated with Gγ. It is likely
that this pool of undimerized Gβ is associated with CCT because it has been
previously shown that Gβ-CCT complexes are relatively stable in the absence of
PhLP1 and Gγ (36). Thus, it appears that the role of CCT is to fold Gβ and protect it
from aggregation or proteolytic degradation until it can be released by PhLP1 to
interact with Gγ.
In conclusion, this work expands the role of PhLP1 as an essential cochaperone in the assembly of all Gβγ combinations. The data provide additional
insight into the broad role PhLP1 assumes to bring the unstable β-propeller fold of Gβ
subunits together with their complementary Gγ to create stable Gβγ dimers in order to
perform their vital functions in G protein signaling.
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CHAPTER 3:
MECHANISM OF PHOSDUCIN-LIKE PROTEIN 1-MEDIATED
Gβ5-R7 RGS ASSEMBLY

Summary
Recent studies have shown that PhLP1 works as a co-chaperone with CCT to
fold Gβ and mediate its interaction with Gγ. However, these studies did not address
the question concerning the role of PhLP1 or CCT in the folding of Gβ5 and its
assembly with R7 RGS proteins. The results show that Gβ5 folding and Gβ5-RGS7
assembly is dependent on CCT and PhLP1, but the apparent mechanism is different
from that of Gβγ. PhLP1 seems to stabilize the interaction of Gβ5 with CCT until
Gβ5 is folded, after which, PhLP1 is released to allow Gβ5 to interact with RGS7.
These findings suggest a CCT-dependent mechanism for Gβ5 folding and Gβ5-RGS7
assembly that utilizes the co-chaperone activity of PhLP1.

Introduction
Once triggered by a ligand-bound GPCR, the G protein Gα subunit exchanges
GDP for GTP causing a decrease in the binding affinity between Gα and Gβγ to the
extent that Gα and Gβγ dissociate from each other. Gα bound to GTP has a higher
affinity for effectors, while the free Gβγ subunit has an exposed effector binding
surface capable of interacting with effector enzymes and ion channels. Formerly, it
was thought that the duration of the G protein signal was dictated by the slow
intrinsic GTPase activity of the Gα subunit. However, this hypothesis could not
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explain the large timing discrepancy between the fast GPCR-mediated physiological
responses measured in vivo and the slow GTPase activity of the Gα subunit in vitro
(77). Theses observations were reconciled when a new family of GTPase
accelerating proteins (GAPs) was identified that were able to bind Gα and
dramatically enhance its intrinsic GTP hydrolysis rate (78, 79). Subsequently, these
proteins were named regulators of G protein signaling (RGS) proteins (78, 79), and to
date, at least 37 RGS proteins have been identified in humans (80). All RGS proteins
contain a distinctive ~120 amino acid sequence through which they bind Gα and
stabilize its switch regions. In the binding process, the position of a key Gα
glutamine residue found in the switch II region is stabilized in a manner that fixes the
catalytic domain in the GTP hydrolysis transition state (81) and orients the
nucleophilic water molecule required for GTP hydrolysis.(82)
Four RGS proteins (6, 7, 9, and 11) contain a central domain similar to the G
protein γ subunit, and as such, this domain has come to be known as the Gγ-like
(GGL) domain. It is through this domain that R7 RGS proteins interact with Gβ5 in a
manner similar to other Gβγ associations (83, 84). Like other Gβγs, Gβ5 and R7
RGS proteins form obligate dimers required for their mutual stability (85), and
without their partner, Gβ5 and R7 RGS proteins are rapidly degraded in cells (85, 86).
Besides the GGL domain, R7 RGS proteins contain an N-terminal DEP (disheveled,
Egl-10, pleckstrin) homology domain and a C-terminal RGS domain (65, 85). The
DEP domain interacts with the membrane anchoring/nuclear shuttling R7 binding
protein (R7BP), or in the case of RGS9, the R9 anchoring protein (R9AP). Through
the RGS domain, Gβ5-R7 RGS complexes act as GAPs for Gi/oa, Gqa and Gαt
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subunits in neuronal cells, some immune cells, and in the retina (75). In addition, the
Gβ5-RGS7 complexes and may also serve to couple inactive Gα subunits to particular
GPCRs (80).
R7 RGS proteins are abundantly expressed in the retina and central nervous
system with RGS9 existing as RGS9-1 in the retina and RGS9-2 in the nervous
system. Because of their mutual dependence, Gβ5 and R7 RGS proteins are
expressed in the same tissues with Gβ5 also found in two alternately spliced forms
(7). The photoreceptor-specific Gβ5-Long (Gβ5L) complexes with RGS9-1 in the
retina, and the more widely expressed Gβ5-short (Gβ5S), forms complexes with
RGS9-2 and other R7 RGS proteins in the nervous system (70).
The physiological function of RGS9-1 has been described in the
phototransduction cascade of mice and humans. In rgs9-1 knockout mice, initial
flash response rates and amplitudes are normal, but the recovery response is much
slower than in the control mice. This is explained by the fact that the rgs9-1
knockout mice showed a significant reduction in GTP hydrolysis in their rod outer
segments leading to a prolonged lifetime of GTP-bound Gαt (86). In humans, it
appears that loss-of-function mutations in either RGS9-1, or its membrane anchoring
protein, R9AP are found in people with bradyopsia, a condition in which
photoresponse recovery is abnormally low. Symptoms of bradyopsia include an
inability to see moving objects which becomes more severe in low lighting, and
difficulty adjusting to changes in light intensity (87). The knockout mice and human
observations are due to an inability of RGS9-1 to properly act as a GAP for Gαtransducin in the phototransduction cascade leading to detrimentally long Gαt
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signaling. Likewise, RGS9-2 operates as a GAP for Gαi to turn off dopaminergic and
opiod signaling in a timely manner. RGS9-2 overexpression in rat brain nucleus
accumbens reduced the response to the dopamine agonist cocaine, while rgs9-2
knockout mice showed a heightened response to the drug (88). In another study,
rgs9-2 knockout mice showed a 10-fold increase in response to the opiate morphine
(88). These results emphasize the necessity of R7-RGS proteins in the precise control
of the duration and amplitude of G protein signaling. The physiological function of
Gβ5, other than stabilizing R7 RGS proteins, is less understood. It is possible that
Gβ5 is needed to keep the RGS protein close to Gα in signaling events that are
extremely fast or sensitive. In this hypothesis, the GDP-bound Gα would bind to
Gβ5, but once in its GTP-bound form, Gα would dissociate from Gβ5, and hydrolyze
its GTP quickly with help from the awaiting R7 RGS protein (74).
In order to understand the molecular mechanisms responsible for the
mentioned physiological responses, the crystal structure of the Gβ5-RGS9 complex
was solved (89) which provides a model for the interaction of Gβ5 with all R7 RGS
proteins. Even though Gβ5 shares only ~50% sequence identity with Gβs 1-4, it was
shown to fold into an almost identical 7-bladed β-propeller structure and bind RGS9
most extensively across the side in a coiled coil analogous to Gβγ binding (32, 89).
Additionally, residues along the top and bottom of the Gβ5 propeller were found in
contact with RGS9 (89). The Gβ5 residues that interact with the GGL domain along
the side of the propeller are conserved between Gβ5 and other Gβs, but the residues
that interact with RGS9 along the top and bottom of the propeller are not. These
divergent residues help explain why Gβ5 is the only Gβ that is able to associate with
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Figure 3-1. Structures of Gβ5-RGS9 and Gαβγ.
Ribbon diagrams of: A) Gβ5 (blue) in complex with RGS9. RGS9 is shown with its Nterminal (light gray), DEP (orange),DHEX (maroon) DHEX-GGL linker (dark gray) GGL
(red), and RGS (green) regions. The RGS9 N-terminal region, DEP domain, and DHEXGGL linker regions bind to the top of the Gβ5 propeller and act as a cap. B) Gαβγ
transducin with Gβ (blue), Gγ (red), Gα (gold), Gα switch regions (magenta), and GDP
(purple). Both the Gα and N-terminal RGS9 binding surfaces overlap on Gβ5. The RGS
N-terminal domains may function as a hinge to allow Gβ5 to simultaneously interact with
Gα and RGS9. Reprinted by permission from Macmillan Publishers Ltd: [Nat
Struct Mol Biol.] (89), copyright 2008. http://www.nature.com/nsmb/index.html

Figure 3-2. Structure of Pdc-Gtβγ.

Ribbon diagrams showing the A) top, and B) side views of Pdc (N-term purple, and Cterm blue) in complex with Gβ1 (gold) and Gγ1 (silver). It is proposed that N-terminal
regions of Pdc and PhLP1 interact similarly with Gβ. As a result, the PhLP1, N-term
RGS9, and Gα binding surfaces on the top of the Gβ propeller overlap. Reprinted by
permission from Elsevier: [Cell] (32), copyright 1996. http://www.cell.com.
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R7 RGS proteins. Structurally, the Gβγ interactions are almost identical to the Gβ5GGL domain associations, but Gγ subunits are not able to form stable complexes with
Gβ5 due to the collective effect of several individually minor residue changes found
in Gβ5. Interestingly, the Gβ residues shown to interact with Gα are conserved in
Gβ5, but RGS9 inhibits the Gα-Gβ5 interaction by capping the top side of the Gβ5
propeller where Gα binds to Gβ. Thus, it is proposed that in vivo several N-terminal
RGS9 residues may act like a hinge, and when opened, uncover the Gβ5 residues
required for interaction with Gα. In addition, the way in which RGS9 caps the top of
the Gβ5 propeller poses a major structural problem for possible Gβ5-PhLP1
interactions because, based on the Pdc-Gβγ crystal structure, PhLP1 is also proposed
to interact with the top of the Gβ5 propeller. In all, it appears that the N-terminal
region of RGS9, Gα, and PhLP1 all share the same Gβ5 binding surface with only
one of these entities able to interact with Gβ5 at a time.
The Gβ5-R7 RGS complex must be folded and assembled in order to carry out
its physiologically important function. The overlapping PhLP1 and RGS9 binding
site on Gβ, as well as a weak ability of Gβ5 to bind CCT relative to other Gβs (55),
led to questions concerning the folding and assembly of Gβ5-R7 RGS proteins. It
was unknown whether Gβ5-R7 RGS assembly could follow the same PhLP1 and
CCT-dependent assembly mechanism as Gβγ dimers (19). PhLP1 and CCT are
absolutely essential in Gβ subunit folding and subsequent Gβγ assembly. How could
Gβ5 fold when it interacted so weakly with CCT, or subsequently associate with an
R7 RGS protein if the association was hindered by PhLP1? Thus, it was not clear
from the available information whether CCT or PhLP1 play a role in Gβ5-R7 RGS
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dimer formation. This report was designed to address this issue using the Gβ5SRGS7 dimer as a model for the assembly of all Gβ5-R7 RGS dimers.

Experimental Procedures
Cell culture
HEK 293T cells were cultured in DMEM/F-12 (50/50 mix) growth media
containing L-glutamine and 15 mM HEPES supplemented with 10% fetal bovine
serum (Sigma-Aldrich). The cells were subcultured regularly to maintain growth, but
were not used beyond 25 passages.
Preparation of cDNA constructs
The pcDNA3.1 vectors containing N-terminally Flag-tagged human Gβs 1
and 5short, N-terminally HA-tagged Gγ2 and 3x HA-tagged RGS7 (S2), were
obtained from the Missouri University of Science and Technology cDNA Resource
Center (www.cdna.org). Wild type human PhLP1 and the PhLP1 Δ1-75 N-terminal
truncation variant each with a 3′ c-myc and His6 tag were constructed in
pcDNA3.1/myc-His B vector using PCR as described (19, 76).
RNA interference experiments
Short interfering RNAs (siRNAs) were chemically synthesized (Dharmacon)
to target nucleotides 608-628 of human lamin A/C (19), nucleotides 345-365 of
human PhLP1 (19), and nucleotides 172-192 of human CCTζ-1 (90). HEK 293T
cells were grown in 12-well plates to 50-70% confluency at which point they were
transfected with siRNA at 100 nM final concentration using Oligofectamine reagent
(Invitrogen) as described previously (19). Twenty four hours later, the cells were
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transfected with 0.5 μg each of Flag-Gβ1 or Flag-Gβ5 and HA-Gγ2 or HA-RGS7 in
pcDNA3.1(+) using Lipofectamine 2000 according to the manufacturer’s protocol
(Invitrogen). The cells were harvested for subsequent immunoprecipitation
experiments 72 hours later. Ten μg of cell lysate were immunoblotted with an antiPhLP1 antibody (35) to assess the percent PhLP1 knockdown, and 20 μg were
immunoblotted with anti-CCTζ and anti-CCTε antibodies (Santa Cruz
Biotechnology) to determine the percent CCT knockdown.
Dominant interfering mutant experiments
HEK 293T cells were plated in 6-well plates and grown to 70-80%
confluency. The cells were then transfected with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Each well was transfected with 1.0 μg
of either the empty vector control, wild-type PhLP1-myc, or PhLP1 Δ1-75-myc along
with 1.0 μg each of the Flag-Gβ5 and HA-RGS7 cDNAs. The cells were harvested
for immunoprecipitation 48 hours after transfection.
Immunoprecipitation experiments
Transfected HEK 293T cells were washed with phosphate-buffered saline
(PBS) (Fisher) and solubilized in immunoprecipitation buffer (PBS pH 7.4, 2% NP40 (Sigma), 0.6 mM PMSF, 6 μl/ml protease inhibitor cocktail per mL buffer (Sigma
P8340). The lysates were passed through a 25-gauge needle 10 times and centrifuged
at maximum speed for 10-12 minutes at 4ºC in an Eppendorf microfuge. The protein
concentration for each sample was determined using the DC Protein Assay Kit II
(Bio-Rad) and equal amounts of protein were used in the subsequent
immunoprecipitations. Approximately 150 μg of total protein were used in
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immunoprecipitations from cells in 12 well plates and 450 μg from cells in 6 well
plates. The clarified lysates were incubated for 30 minutes at 4°C with 2.5 μg antiFlag antibody (clone M2, Sigma), 1 μg anti-CCTε (clone PK/29/23/8d Serotec), 1.75
μg anti-myc (clone 9E10, BioMol), or 1.5 μg anti-HA (clone 3F10 Roche) for lysates
from 12-well plates or with 6.25 μg of anti-Flag for lysates from 6-well plates. Next,
30 μl of a 50% slurry of Protein A/G Plus agarose (Santa Cruz Biotechnology) was
added, and the mixture was incubated for 30 minutes at 4°C as described (19). The
immunoprecipitated proteins were solubilized in SDS sample buffer and resolved on
a 10% Tris-Glycine-SDS gel or a 16.5% Tris-Tricine-SDS gel for Gβ1γ2. The
proteins were transferred to nitrocellulose and immunoblotted using an anti-Flag
(clone M2, Sigma), anti-c-myc (BioMol), anti-HA (Roche), or an anti-PhLP1
antibody (19). Immunoblots were incubated with the appropriate anti-rabbit, antimouse, anti-goat (Li-Cor Biosciences), or anti-rat (Rockland) secondary antibody
conjugated with an infrared dye. Blots were scanned using an Odyssey Infrared
Imaging System (Li-Cor Biosciences), and protein band intensities were quantified
using the Odyssey software. The data are presented as the mean value +/- standard
error from at least three experiments.
Radiolabel pulse-chase assays
Radiolabel pulse-chase assays were preformed as previously described (19).
Briefly, siRNA-treated or transfected HEK 293T cells in 12-well plates were washed
once with 1.5 ml of methionine-free DMEM media (Mediatech) and then incubated in
1 ml of this same media at 37°C for 1 hour. The media was discarded and 400 μl of
media supplemented with 200 μCi/ml radiolabeled L-[35S] methionine (Perkin-Elmer)
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was added. The cells were incubated in the radiolabeled media for 10 minutes at
23°C. Subsequently, the cells were washed once with 1.6 ml of DMEM media
supplemented with 4 mM nonradiolabeled L-methionine (Sigma) and 4 μM
cycloheximide to remove the radiolabeled media and then incubated in 0.8 ml of this
same media at 23°C for the chase times indicated. After the chase periods, the cells
were harvested for immunoprecipitation. Radiolabeled gels were visualized with a
Storm 860 phosphorimager, and the band intensities were quantified using Image
Quant software (GE Healthcare). The molar ratios were determined by normalizing
the band intensities to the number of methionine residues found in Flag-Gβ1, HAGγ2, Flag-Gβ5, or HA-RGS7 and then calculating the ratios. The molar ratios were
consistently substoichiometric, with the HA-Gγ2/Flag-Gβ1 ratio reaching ~ 0.4 by 60
minutes of chase (Fig. 3-6C) and the HA-RGS7/Gβ5 ratio reaching ~ 0.1 by 60
minutes of chase (Figs. 3-5A and 3-6B). The lower HA-RGS7/Gβ5 ratio probably
results from less efficient synthesis and folding of the nascent RGS7 compared to
nascent Gβ5. In addition, non-complexed Gβ5 may be more stable than other noncomplexed Gβs. In vitro experiments have shown that Gβ5 is more stable in solution
than other Gβs when neither are complexed with Gγ (7). The rate data for Gβγ and
Gβ5-RGS7 assembly were fit to a first-order rate equation with background
correction to determine the rate constant for assembly.
Protein purifications
Gβ1γ2, Gβ5γ2 and Gβ5-RGS9-1 were expressed and purified from insect
cells. Recombinant baculovirus constructs were generously provided by Narasimhan
Gautam of Washington University (Gβ1 (91)), James Garrison from the University of
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Virginia (Gβ5 and Gγ2 (92)) and Ching-Kang Chen from Virginia Commonwealth
University (RGS9-1 (93)). The Gγ2 subunit contained both a His6 tag and a Flag
epitope tag on the N-terminus. The RGS9-1 subunit contained only a Flag epitope
tag on the C-terminus. Sf9 cells (GIBCO) were grown to a density of 2 x 106 cell/ml
and then co-infected with a Gβ and Gγ2 or RGS9-1 baculovirus at an MOI of 5 for
each virus type. Cells were grown in shaker culture for ~ 60 hours and were pelleted
by centrifugation at 250 x g for 10 min. at 4°C. The supernatant was discarded and
the cell pellet was snap frozen in liquid nitrogen and stored at -80°C.
Gβ1γ2 and Gβ5γ2 were purified by a modification of a previously described
protocols (92, 94). The cell pellet from 1 L of cells was thawed and resuspended in
100 mL of Homogenization Buffer (20 mM HEPES pH 7.5, 3 mM MgCl2, 150 mM
NaCl, 2 μg/mL aprotinin, 2 μg/mL leupeptin, 2 μg/mL pepstatin, 20 μg/mL
benzamidine and 0.1 mM PMSF). The suspension was sonicated with a tip sonicator
on ice and centrifuged at 100,000 x g for 1 hour. The pellet was homogenized in 100
mL of Extraction Buffer (Homogenization Buffer + 0.1% polyoxyethylene 10 laurel
ether) using a Dounce homogenizer and stirred on ice for 1 hour. The suspension was
centrifuged again at 100,000 x g for 1 hour. The supernatant was collected and
applied to a 5 mL M2 Flag agarose column (Sigma Aldrich) equilibrated in
Extraction Buffer. The column was washed with 30 mL of Extraction Buffer and the
Gβγ dimers were eluted with 15 mL of Flag Elution Buffer (Extraction Buffer plus
250 μg/mL Flag peptide). Fractions containing the purified dimers were combined
and applied to a 2 mL Ni2+ NTA column (Novagen) equilibrated in Extraction Buffer
plus 30 mM imidazole. The column was washed with 20 mL of this buffer and the

48

eluted with 10 mL of Extraction Buffer plus 500 mM imidazole. Fractions containing
Gβγ were combined and dialyzed in Extraction Buffer plus 50% glycerol, which
caused a 4-fold increase in protein concentration. Gβ5-RGS9-1 was purified the
same way except the Ni2+ NTA column was skipped because the RGS9-1 protein did
not contain a His6 tag. This procedure generally resulted in ~ 1 mL of ~ 1 mg/mL
protein that was 90% pure.
Metabolically labeled 35S-PhLP1 was prepared by transforming DE3 E. coli
cells with a PhLP1 pET15b vector (22) and inoculating 100 mL of M9 minimal media
with a single colony of cells. The culture was incubated ~ 20 hours at 37°C until the
absorbance at 600 nm reached 0.6-0.7. The cells were collected by centrifugation and
resuspended in 100 mL of reduced Na2SO4 M9 minimal media. At this point, 12 mg
of isopropyl-β-D-thiogalactopyranoside was added along with 500 μL of 2 mCi/mL
[35S]-H2S04. The culture was grown for 3.5 hours at 37°C to an absorbance at 600
nm of ~1.0. The labeled PhLP1 was then purified as described previously (22).
In vitro binding assays
The binding of 35S-PhLP1 to Gβγ or Gβ5-RGS9-1 dimers was determined by
mixing 35 μL of a 50% slurry of M2 Flag agarose beads equilibrated in Assay Buffer
(Extraction buffer without protease inhibitors) with purified Gβγ or Gβ5-RGS9-1
(final concentration 0.5 μM). The 35S-PhLP1 was then added to the reaction mixture
at final concentrations ranging from 0.01 μM to 2 μM in a total reaction volume of
150 μL. The reaction mixture was incubated on a rotator at 4°C for 1 hour. Each
reaction was briefly vortexed and 50 μL of the mixture was counted in a scintillation
counter to obtain the total amount of PhLP1 added. Each reaction was then
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centrifuged for 1 min. at 1000 x g to separate the bound from the free 35S-PhLP1. A
50 μL aliquot of the supernatant was then counted as described above to obtain the
free counts. The free counts were subtracted from the total counts to determine the
counts of bound 35S-PhLP1. Non-specific binding was determined by running the
assay in parallel with Flag-glutathione-S-transferase in place of Gβγ or Gβ5-RGS9-1.
The specific binding was determined by subtracting the non-specific binding from the
total binding. Counts were converted into concentration units using the specific
activity of the 35S-PhLP1. The concentration of specifically bound 35S-PhLP1 was
then plotted verses the free PhLP1 concentration, and the Kd for the interaction was
determined by fitting the data to a one-to-one binding equation: B =
Bmax/(1+Kd/[PhLP1]); where B is the amount of PhLP1 bound to the beads, Bmax is
the maximal binding of PhLP1 and Kd is the dissociation constant for the interaction.

Results
An important question regarding the scope of PhLP1-mediated dimer
assembly is whether PhLP1 assists in the formation of Gβ5-R7 RGS protein
complexes. Gβ5 binds both CCT (55) and PhLP1 (Fig. 2-1) weakly compared to the
other Gβ subunits, suggesting that CCT and PhLP1 may not be required for Gβ5-R7
RGS dimer assembly. To begin to address this issue, the effects of PhLP1
knockdown and PhLP1 Δ1-75 over-expression on the interaction of Gβ5 with RGS7
were assessed by co-immunoprecipitation as in Fig. 2-1. PhLP1 knockdown
decreased both Gβ5 expression and RGS7 co-immunoprecipitation with Gβ5 by 40%
(Fig. 3-3A). This result is in contrast to the Gβγ co-immunoprecipitation data which
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showed a similar 40% decrease in Gβ1 and Gβ2 expression, but exhibited a much
greater decrease (80-90%) in the amount of Gγ co-immunoprecipitating with Gβ upon
PhLP1 knockdown (Figs. 2-1B and 2-3A). The results were similar in the dominant
interference experiments (Fig. 3-3B). Over-expression of wildtype PhLP1 increased
Gβ5 expression by ~2-fold over the empty vector control, as was observed with Gβ1
and Gβ2 (Figs. 2-2A and 2-4A). However, the proportional increase in coimmunoprecipitation seen with Gγ2 (Fig. 2-2A and 2-4A) was not observed with
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Flag-Gβ5
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Fig. 3-3. Effects of PhLP1 on the assembly of RGS7 with Gβ5.
A) HEK 293T cells were treated with siRNA against PhLP1, lamin A/C, or no siRNA as
indicated. Twenty-four hours later, cells were transfected with HA-RGS7 and Flag-Gβ5
cDNAs. After 72 additional hours, cells were lysed, immunoprecipitated with an anti-Flag
antibody and immunoblotted with anti-Flag or anti-HA antibodies. Bands were quantified
and expressed as a percentage of the lamin A/C control. PhLP1 knockdown was measured
by quantifying the PhLP1 band intensity in immunoblots of 10 μg of whole cell lysate. B)
Cells were transfected with either WT PhLP1, PhLP1 Δ1-75, or an empty vector control
along with HA-RGS7 and Flag-Gβ5 cDNAs. After 48 hours, cells were lysed,
immunoprecipitated with an anti-Flag antibody and immunoblotted with anti-Flag or antiHA antibodies. Bands were quantified and expressed as a percentage of the wild-type
PhLP1 control. Bars represent the average ± standard error from 3 separate experiments.
Representative blots are shown below the graphs.
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RGS7, which showed a much smaller increase. Moreover, overexpression of PhLP1
Δ1-75 did not cause the dramatic decrease in RGS7 co-immunoprecipitation that was
observed with Gγ2 (Fig. 3-3B). These findings suggest that the effect of PhLP1 on
the expression of Gβ5 is similar to the other Gβs but that PhLP1 may not be as
important in Gβ5-RGS7 assembly as it is in Gβγ assembly.
The findings of Fig. 3-3 point to potentially significant differences between
the mechanisms of Gβ5-RGS7 assembly and Gβγ assembly. Gβ5-RGS7 assembly
was further investigated to better understand the role of PhLP1 and CCT in this
process. If CCT were involved in Gβ5 folding, the two would have to interact, yet
Gβ5 has been reported to bind CCT poorly in vitro (55). To further test the ability of
Gβ5 to interact with CCT, the co-immunoprecipitation of overexpressed Gβ5 with
endogenous CCT in HEK-293T cells was measured. Gβ5 was readily detected in the
CCT immunoprecipitate, but the amount was 20-fold less than that of Gβ1 (Fig. 34A), confirming the finding that Gβ5 binds CCT much less than other Gβs.
Importantly, coexpression of PhLP1 increased Gβ5 binding to CCT by nearly 10-fold
(Fig. 3-4B), indicating that PhLP1 stabilizes the interaction of Gβ5 with CCT
considerably. In contrast, co-expression of RGS7 had no effect on Gβ5 binding to
CCT. These results are very different from the effect of PhLP1 and Gγ2 on Gβ1
binding to CCT in which both PhLP1 and Gγ2 contributed significantly to the release
of Gβ1 from the CCT complex (36). Thus, it appears that the role of PhLP1 in the
binding of Gβ1 and Gβ5 to CCT are opposite – with PhLP1 assisting in the release of
a tightly binding Gβ1 while stabilizing the weak interaction of Gβ5.
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To complete the investigation of CCT interacting partners in the Gβ5-RGS7
dimer, the binding of RGS7 was also measured by co-immunoprecipitation with
CCT. No RGS7 bound CCT when RGS7 was over-expressed alone, but coexpression of Gβ5 caused a detectible amount of RGS7 to co-immunoprecipitate with
CCT (Fig. 3-4C). In contrast, co-expression of PhLP1 with RGS7 did not cause
RGS7 to bind CCT and coexpression of PhLP1 together with Gβ5 and RGS7 did not
increase RGS7 co-immunoprecipitation with CCT. The total amount of RGS7 in the
cell lysate also increased significantly upon Gβ5 coexpression, consistent with the
fact that R7 RGS proteins require Gβ5 for stable expression in the cell (86). These
results suggest that in the process of Gβ5-RGS7 assembly Gβ5 recruits RGS7 to
CCT. The lack of effect of PhLP1 on RGS7 binding to CCT suggests that PhLP1
does not play a role in this recruitment. To further test this notion, RGS7 and PhLP1
were co-expressed with and without Gβ5 and their ability to co-immunoprecipitate
each other was measured. Neither protein was found in the immunoprecipitate of the
other in the presence or absence of Gβ5 (Fig. 3-4D), indicating that RGS7 and PhLP1
do not exist in any complexes together. From these binding experiments, it appears
that PhLP1 stabilizes the interaction of Gβ5 with CCT and that Gβ5 recruits RGS7 to
CCT, but only after PhLP1 has been released from the complex. The data from
Figures 3-3 and 3-4 suggest that PhLP1 may be involved in the folding of Gβ5 by
stabilizing its interaction with CCT but that PhLP1 may not participate in Gβ5-RGS7
assembly. This concept was further tested by measuring the effect of PhLP1
knockdown or over-expression on the rate of Gβ5-RGS7 dimerization. In these
experiments, PhLP1 was either siRNA-depleted or over- expressed in HEK-293T
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cells and the rate of Gβ5-RGS7 dimer formation was measured in a pulse chase
experimental format (19). PhLP1 knockdown resulted in a two-fold decrease in the
rate of Gβ5-RGS7 dimerization compared to a control siRNA (Fig. 3-5A), which is
somewhat less than the five-fold decrease in the rate of Gβ1γ2 dimerization observed
with a similar PhLP1 knockdown (19). In contrast, the effects of PhLP1 over-
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Fig. 3-4. Effects of PhLP1 and RGS7 on the binding of Gβ5 to CCT.
A) Binding of Gβ5 to CCT was compared to that of Gβ1 by co-immunoprecipitation.
HEK 293T cells were transfected with cDNAs for Flag-Gβ1, Flag-Gβ5 or an empty vector
control as indicated. After 48 hours, cells were lysed, immunoprecipitated with an antiCCTε antibody and immunoblotted with anti-Flag antibodies. Bands were quantified and
the binding of Gβ5 to CCT was expressed relative to that of Gβ1. Bars represent the
average ± standard error from 3 separate experiments and representative blots are shown
below the graphs. (The Gβ5 error bar is very small.) For all experiments A-D, the
expression of each transfected cDNA was confirmed by immunoblotting 5 μg of whole
cell lysate with the antibodies indicated. B) The effect of PhLP1 and RGS7 on the binding
of Gβ5 to CCT was measured by co-immunoprecipitation as in panel A. Cells were
transfected with the indicated cDNAs, and CCT was immunoprecipitated and
immunoblotted for Flag-Gβ5. Bands were quantified and expressed relative to the FlagGβ5/HA-RGS7 sample. Data are from 8 separate experiments. C) The effects of PhLP1
and Gβ5 on RGS7 binding to CCT was measured by co-immunoprecipitation as in panel
A. Cells were transfected with the indicated cDNAs and CCT was immunoprecipitated
and immunoblotted for HA-RGS7. Bands were quantified and expressed relative to the
Flag-Gβ5/HA-RGS7 sample. Data are from 3 separate experiments. D) The ability of
PhLP1 and RGS7 to co-exist in CCT or other complexes was tested by coimmunoprecipitation. Cells were transfected with cDNAs to PhLP1-myc and HA-RGS7
with or without Flag-Gβ5, immunoprecipitated with anti-myc or anti-HA antibodies and
immunoblotted with these same antibodies as indicated. The resulting blots are shown.

expression on the rate of Gβ5-RGS7 assembly were strikingly different than what
was observed for Gβ1γ2 assembly. PhLP1 overexpression actually caused a small
decrease in the rate of Gβ5-RGS7 assembly (Fig. 3-5B), while it resulted in a 4-fold
increase in the rate of Gβ1γ2 assembly (19). Interestingly, PhLP1 overexpression
increased the amount of Gβ5 produced during the 10 min. pulse by 40%, which in
turn caused a small increase in RGS7 co-immunoprecipitation. However, the net
effect was a decrease in the RGS7/Gβ5 ratio, indicating an inhibition of RGS7/Gβ5
dimer formation despite the fact that more Gβ5 was available for assembly. It is clear
from these results that the role of PhLP1 in Gβ5-RGS7 assembly is much different
than its role in Gβγ assembly. It appears that endogenous levels of PhLP1 may
contribute to Gβ5-RGS7 assembly by stabilizing the interaction of Gβ5 with CCT,

55

but that excess PhLP1 inhibits Gβ5-RGS7 assembly, possibly by interfering with the
Gβ5-RGS7 interaction.
The recently published structure of the Gβ5-RGS9 complex (89) suggests a
possible reason for the observed inhibition of Gβ5-RGS7 assembly by excess PhLP1.
In the structure, the Gγ-like domain interacts along the expected Gγ binding surface
of Gβ5, opposite the predicted PhLP1 binding site (89). However, the N-terminal
lobe of RGS9 interacts with Gβ5 on the same surface as PhLP1 (32, 89). This
overlap may preclude the formation of a PhLP1-Gβ5-RGS7 complex analogous to the
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Fig. 3-5. Effects of PhLP1 on the rate of Gβ5-RGS7 dimer formation.
A) The rate of Gβ5-RGS7 dimer assembly was measured in HEK-293T cells with or
without PhLP1 knockdown. Cells were treated with PhLP1 or lamin A/C siRNAs as
indicated. Twenty-four hours later, the cells were transfected with Flag-Gβ5 and HARGS7 cDNAs. After 72 additional hrs, nascent polypeptides were labeled for 10 min
with [35S] methionine and then chased with unlabeled methionine and cycloheximide. At
the chase times indicated, the Flag-Gβ5 was immunoprecipitated and the proteins were
separated by SDS-PAGE. The radioactive bands were visualized and quantified using a
phosphorimager and the molar ratio of Gβ5 to RGS7 was calculated. The data points
represent the average ± standard error from 3 separate experiments, and lines represent
fits of the data to a first order rate equation. A representative gel is shown below the
graph as is a PhLP1 immunoblot of 10 μg of whole cell lysate showing the degree of
siRNA knockdown. B) HEK-293 cells were transfected with Flag-Gβ5 and HA-RGS7
with and without PhLP1-myc cDNAs for 48 hrs and the rate of Gβ5-RGS7 assembly was
measured using the pulse-chase assay as in panel A. The data are from 3 separate
experiments. C) The binding of the indicated concentrations of 35S-PhLP1 to 0.5 μM
purified Gβ1γ2 (●), Gβ5γ2 (○) or Gβ5-RGS9-1 (▲) was measured by in vitro coimmunoprecipitation (see Experimental Procedures). Symbols represent the average ±
standard error from 3 separate experiments. Lines represent non-linear least squares fits
of the data to a one-to-one binding equation. The fits yielded Kd values of 83 ± 13 nM for
Gβ1γ2, 440 ± 70 nM for Gβ5γ2 and no measurable value for Gβ5-RGS9-1.

PhLP1-Gβγ complex that is believed to be an intermediate in Gβγ assembly (19, 36).
To test this possibility, the binding of PhLP1 to the Gβ5-RGS9-1 complex was
measured. An in vitro assay was preformed in which Gβ5-RGS9-1 was immobilized
on Flag antibody-linked agarose beads via a Flag tag on the RGS9-1. Increasing
concentrations of metabolically labeled 35S-PhLP1 were added to the beads and
allowed to reach equilibrium. The beads were pelleted and the amount of bound and
free 35S-PhLP1 was determined. The results show that indeed there was no
measurable binding of PhLP1 to Gβ5-RGS9-1 (Fig. 3-5C). In contrast, PhLP1
readily bound Gβ1γ2 and to a lesser extent Gβ5γ2 in this assay. The dissociation
constants for the interactions were 83 ± 13 nM for Gβ1γ2 and 440 ± 72 nM for
Gβ5γ2. The Kd for Gβ1γ2 binding is similar to the 107 nM Kd reported previously
for the PhLP1-Gβ1γ1 interaction using surface plasmon resonance methods (22), so
the assay appears to be measuring the binding accurately. The inability of Gβ557

RGS9-1 to bind PhLP1 suggests that excess PhLP1 interferes with Gβ5-RGS7 dimer
formation because it binds Gβ5 in a manner that does not allow RGS7 to
simultaneously interact.
The binding of Gβ5 to CCT and the Gβ5-dependent recruitment of RGS7 to
CCT suggest an important role for CCT in the Gβ5-RGS7 assembly process. This
possibility was tested further by measuring the effect of CCT knockdown on the rate
of Gβ5-RGS7 dimerization using the pulse/chase assay. An siRNA to CCTζ that
results in a substantial knockdown of CCT complexes has been reported (90, 95).
Using this siRNA, CCTζ expression was decreased by 50% in HEK-293T cells (Fig.
3-6A). In addition, expression of the CCTε subunit was also decreased by a similar
amount (Fig. 3-6A), indicating that expression of the entire CCT complex was
reduced by 50%. This reduction in CCT resulted in a proportional decrease in the
rate of Gβ5-RGS7 assembly of 50% (Fig. 3-6B), suggesting that Gβ5-RGS7 assembly
is very dependent on CCT. For comparison, the effect of this CCT knockdown on
Gβγ assembly, which is expected to be CCT-dependent (36, 55), was also measured.
The 50% reduction in CCT caused a similar 50% decrease in the rate of Gβγ
assembly (Fig. 3-6C), confirming the importance of CCT in Gβγ formation. The
striking similarity of these effects of CCT knockdown on the rates of both Gβ5-RGS7
and Gβγ dimerization show that Gβ5-RGS7 assembly is just as dependent on CCT as
Gβγ assembly. Together, the data in Figs. 3-5 and 3-6 indicate a similar role for CCT
in both Gβ5-RGS7 and Gβγ assembly, but a much less critical role for PhLP1 in Gβ5RGS7 assembly compared to its essential role in Gβγ assembly.
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Fig. 3-6. Effects of CCT on the rate of Gβ5-RGS7 dimer formation.
A) HEK-293T cells were treated with CCTζ or lamin A/C siRNA for 96 hrs and the
expression of CCTζ and CCTε was measured by immunoblotting 20 μg of whole cell
lysate. Representative blots are shown. B) The rate of Gβ5-RGS7 dimer assembly was
measured in HEK-293T cells with or without CCTζ knockdown as in Fig. 8A. The data
are from 3 separate experiments. C) The rate of Gβ1γ2 dimer assembly was measured
in HEK-293T cells with or without CCTζ knockdown as in Fig. 8A. The data are from
3 separate experiments.

Discussion
Mechanistic studies have thus far focused on the most common Gβ1γ2 dimer
combination and have not addressed whether this assembly mechanism applies to
Gβ5-RGS dimmer formation. The data presented here suggest a very different
assembly mechanism for Gβ5-RGS7 dimers than that of Gβγ. An outline of a
possible mechanism for Gβ5-RGS7 assembly that is consistent with the data
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presented is depicted in Fig. 3-7. The decrease in the rate of Gβ5-RGS7 assembly
upon siRNA mediated CCT knockdown (Fig. 3-6B) indicates that CCT is involved in
the assembly process, most likely by folding the nascent Gβ5 despite the weak
interaction of Gβ5 with CCT. Likewise, the decrease in the rate of Gβ5-RGS7
assembly upon PhLP1 knockdown (Fig. 3-5A) shows that PhLP1 also contributes to
the assembly process, possibly by increasing the efficiency of Gβ5 folding by
increasing the binding of Gβ5 to CCT through the formation of a stable PhLP1-Gβ5CCT ternary complex (Fig. 3-4B). However, the decrease in the rate of Gβ5-RGS7
assembly upon over-expression of PhLP1 (Fig. 3-5B) indicates that excess PhLP1
interferes with the assembly process. A logical explanation of this effect is that
PhLP1 must be released from Gβ5 prior to its interaction with RGS7 and that excess
PhLP1 blocks the association of RGS7 with Gβ5. Once PhLP1 is released, it appears
that RGS7 can associate with Gβ5 while still bound to CCT, given the fact that Gβ5
initiates the co-immunoprecipitation of RGS7 with CCT (Fig. 3-4C). Once formed,
the Gβ5-RGS7 complex would be expected to readily release from CCT because of
the relatively weak interaction of the complex with CCT (Fig. 3-4B and C). The
folded and assembled Gβ5-RGS7 complex would then be able to interact with its R7
anchoring protein and with its Gα targets.
The unique roles for PhLP1 in Gβ5-RGS7 verses Gβγ dimer formation can be
understood by examining the structures of the complexes. In the case of Gβγ, the Gγ
binding surface is on the opposite side of Gβ from the principle PhLP1 binding
surface (32), allowing PhLP1 and Gγ to interact with Gβ simultaneously. It has been
proposed that this configuration allows nascent Gγ to associate with Gβ while the Gβ
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Fig. 3-7. Proposed Model of Gβ5-RGS7 assembly.
A speculative model of the mechanism of Gβ5-RGS7 assembly that is consistent with
current data is depicted. In this model, Gβ5 binds CCT, but is unable to fold into its
seven-bladed β-propeller structure (illustrated by the gap in the Gβ5 heptagon) without
PhLP1. PhLP1 binding increases the interaction of Gβ5 with CCT, allowing folding to
occur (Fig. 7B). PhLP1 is then released, perhaps by ATP binding to CCT. The folded
Gβ5 is then able to interact with RGS7 on CCT. The initial interaction is most likely via
its N-terminal DEP/DHEX domain because this domain binds the same face of Gβ5 as
PhLP1 (89). Once formed, the Gβ5-RGS7 can release from CCT as a functionally active
dimer.

β-propeller is being stabilized by PhLP1 (36). In the case of Gβ5-RGS9, the Nterminal lobe of RGS9 covers a 2600 Å2 area on the same face of Gβ5 (89) predicted
to bind PhLP1, based on the phosducin-Gβ1γ1 structure (32). In fact, several residues
of Gβ5 that contact the N-terminal lobe of RGS9 are also expected to contact PhLP1
(32, 89). Because of this overlap, assembly of the Gβ5-RGS complex apparently can
not proceed through a PhLP1-Gβ5-RGS intermediate. A question that is not clear
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from the structures is how PhLP1 assists in the release of Gβ1 from CCT, while it
stabilizes the binding of Gβ5 to CCT. More structural information on the PhLP1-GβCCT complexes for both the Gβ1 and Gβ5 complexes would be required to
understand the underling molecular basis for these disparate binding properties.
Perhaps the differences lie more in the interactions of the Gβ subunits with CCT, with
Gβ1 making high-affinity contacts and Gβ5 making only low-affinity contacts in the
absence of PhLP1. Upon PhLP1 binding, it is possible that both Gβ1 and Gβ5 form a
similar complex with CCT in which the high-affinity contacts of Gβ1 have been lost
but indirect contacts with CCT through PhLP1 have been gained, thereby increasing
the binding of Gβ5 to CCT.
In conclusion, this work expands the role of PhLP1 and CCT as essential
chaperones in the folding and assembly of the Gβ5-RGS7 dimer. The Gβ5-RGS7
assembly mechanism is similar to Gβγ assembly in its CCT dependence but differs
significantly in its PhLP1 dependence. The data provide additional insight into the
intricate means by which the cell utilizes its molecular chaperones to bring the
unstable β-propeller fold of the Gβ5 subunit together with the complementary RGS
protein to create stable Gβ5-RGS7 dimers to perform their vital functions in G protein
signaling.
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CHAPTER 4:
PhLP2 FUNCTION AND PHOSPHORYLATION

Introduction
PhLP2, an essential protein, is a member of the Pdc family
Proteins in the phosducin II subfamily were revealed in an analysis of 33
phosducin family protein sequences from different organisms. Pdc and PhLP1 were
classified as subfamily I proteins, while PhLP2 and PhLP3 were assigned to
subfamilies II and III, respectively (21). All Pdc family proteins contain a central
thioredoxin-like domain and a charged C-terminus, but differ in their N-terminal
regions (21). Strikingly, PhLP2 proteins were found to be essential in Saccharomyces
cerevisiae (29) and Dictyostelium discoideum (21). Deletion of phlp2 in yeast yielded
spore products which failed to grow while disruption of the gene in Dictyostelium
caused a decreasing growth rate and simultaneous collapse of the cell culture after 1617 cell divisions (21, 29). A unique function for PhLP2A in comparison to other
members of the Pdc family was confirmed when overexpression of yeast PhLP3 was
not able to complement the phlp2Δ mutation (29), and deletion of phlp1 in
Dictyostelium led to a phenotype similar to Gβ deletion rather than inviability (21).
Conversely, expression of a mouse phlp2 gene was able to complement the defects of
the phlp2Δ mutant in yeast, indicating an evolutionarily conserved function from
yeast to mammals (27).
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PhLP2 does not participate in G protein signaling
When PhLP2 was first discovered, it was unknown whether or not it would
play a role in G protein signaling because unlike like Pdc or PhLP1, PhLP2 does not
contain an 11-amino acid Gβγ binding sequence in its N-terminal domain (21).
Additionally, of the 32 total Pdc amino acids known to bind Gβγ in Dictyostelium,
only 10 of these are conserved in PhLP2 (21). Accordingly, initial empirical results
proved that PhLP2 bound Gβγ very weakly in yeast (29). Further evidence for a
distinctive PhLP2 function was found when it was revealed that PhLP2 was not
involved in the pheromone-induced G protein mating response in yeast. Upon
pheromone induced GPCR activation, Gα and Gβγ dissociate and Gβγ activates a
downstream MAP kinase signaling cascade in which the MAP kinase kinase Ste7 is
involved. Many cellular responses ensue and among them is a cell cycle arrest in the
G1 phase which is required to synchronize the cell cycles of the two mating partners
(96). Normally, the G1 arrest is short lived and the cell cycle resumes as the mating
process completes. However, if Gα is mutated so that it cannot bind and inhibit Gβγ
signaling, constitutive G1 arrest occurs due to sustained Gβγ activation of the MAP
kinase pathway. This type of arrest can be rescued by a loss-of-function mutation in
the ste7 gene which stops downstream activation (96). When PhLP2 was
overexpressed in yeast, there was no defective or heightened G protein-dependent
mating response seen in response to pheromone (29), and similarly, yeast phlp2
temperature sensitive mutants showed no change in their sensitivity to pheromone
response at restrictive temperature (58). G1-S growth arrest was observed in phlp2Δ
mutants before death, but was unrelated to the growth arrest seen in response to
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pheromone-induced G protein activation since phlp2 Δ arrested cells could not be
rescued by a ste7 loss-of-function mutation (29). Altogether, these results led to the
hypothesis that PhLP2 has a separate function from Pdc or PhLP1 in that it does not
participate in G protein signaling.
PhLP2 is a co-chaperone with CCT in the folding of essential proteins
Nevertheless, like PhLP1, PhLP2 is capable of binding to CCT (58, 97, 98).
CCT is an essential cytosolic chaperonin which folds two well characterized
substrates, actin and tubulin, and other substrates with some containing high β-sheet
content which are difficult to fold (48, 50, 51, 53, 99). It is hypothesized that PhLP2
binds CCT in a manner analogous to PhLP1 or prefoldin, that is, as a co-chaperone in
its native form, and not as a folding substrate (38, 52, 53, 58). Due to its essential
function, it was thought that PhLP2 could act as a co-chaperone with CCT in the
folding of one or more essential proteins. However, since no function for PhLP2 in G
protein signaling was found, it is unknown which essential proteins could be PhLP2
folding substrates. Recently, evidence for a role in folding actin, tubulin, some cell
cycle proteins, and possibly even apoptotic proteins was established using
temperature sensitive yeast mutants and siRNA mediated PhLP2 knockdown (28, 58).
Because PhLP2 is essential in yeast, its function was studied by way of
temperature sensitive mutants (phlp2-ts) (58). The molecular basis for the
temperature sensitivity was unknown, but these mutants grew well at permissible
temperatures with normal PhLP2 function but began to show PhLP2-related defects at
higher, non-permissible temperatures. Among the defects were a heightened
sensitivity to the microfilament disrupting drug latrunculin, and a modest sensitivity
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to the microtubule disrupting drug benomyl, indicating that the phlp2-ts mutants had
predisposed defects in actin and possibly tubulin organization (58). Disrupted actin
function or polymerization was again suggested by the observation that the phlp2-ts
mutant cells were significantly larger than wild type cells at both the permissible and
non-permissible temperatures, and furthermore, the phlp2-ts cells displayed budding
defects, improper nucleus segregation, multi-nucleated and anucleated cells, and the
abolishment of actin cables at the non-permissible temperatures (58). Thus, the
phlp2-ts mutant defects gave strong evidence for a PhLP2 role in actin folding, and
some evidence for a role in tubulin folding. In vitro, human PhLP2A bound actin and
tubulin, but was shown to only bind actin indirectly. PhLP2A only associated with
actin when it was found in a PhLP2A-actin-CCT ternary complex (58). Strangely, in
vitro actin folding was inhibited by the addition of PhLP2 to the complex, even
though PhLP2 increased the amount of actin bound to CCT and prefoldin (58). The
discrepancies between in vivo and in vitro observations are probably due an
overabundance of PhLP2 which may lead to an inhibitory role as an overabundance
of PhLP1 is able to inhibit Gβγ assembly (17). The PhLP2:CCT ratio was 100:1 in
the in vitro experiments whereas a global analysis of protein expression in yeast
revealed that the ratio is about 1:1 in vivo (58, 100). A lack of folding cofactors, or
PhLP2A phosphorylation not present in the in vitro system may have also led to actin
folding inhibition.
In addition to actin defects, the yeast phlp2-ts mutants were inhibited at the
G1-S cell cycle transition with a significant delay in DNA replication at nonpermissible temperatures (58, 100). The G1-S delay seen in the phlp2-ts mutants was
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rescued by overexpression of several genes known to promote G1-S transition thus
showing that driving cells through G1-S helped to relieve the phlp2-ts cell cycle
defects (58). This finding, along with the fact that entry into S phase occurs
independent of actin function (101), led to the belief that PhLP2 is involved in the
folding of proteins involved in yeast cell cycle progression such as CDC20, CDH1,
CDC55 (58). Interestingly, PhLP2 was shown in two separate yeast-two hybrid
assays to bind to the bait protein CSM1, which is involved in DNA replication and
binds several members of the mini chromosome maintenance (MCM) prereplicative
complex. (102, 103). The MCM complex forms a ring structure and possesses DNA
helicase activity required for the initiation of eukaryotic DNA replication (103). The
reason for the PhLP2-CSM1 interaction was not determined, but it may link PhLP2 to
DNA replication. And finally, PhLP2 was implicated in apoptosis when PhLP2 was
shown to be ubiquitinated by an inhibitor of apoptosis protein (IAP) and siRNAmediated PhLP2 knockdown in HEK 293T cells led to an inability to process
caspase-3 following Bax-induced cell death (28).
PhLP2A and CCT mutants display similar phenotypes
Temperature sensitive cct (cct-ts) or phlp2-ts mutants exhibit similar
phenotypes in yeast indicating that their functions are cooperative. Like phlp2-ts
mutants, cct-ts mutants showed cytoskeletal disorganization at restrictive
temperatures (58, 104). Specific CCT subunits are responsible for binding certain
substrates, and therefore, mutations in different CCT subunits produced different
abnormalities in actin and microtubule organization. Yeast harboring a temperature
sensitive mutation separately to each CCT subunit exhibited phenotypes with
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differing severities in actin and tubulin malfunction (104). Interestingly, like phlp2-ts
mutants, the cctδ-ts mutants exhibited phenotypes indicative of altered actin
assembly, but were nearly normal in their microtubule organization with only a small
percentage of cells showing signs of abnormal microtubule organization (104).
PhLP2 and CCT are both necessary for normal progression through the G1-S
transition of the cell cycle and significant CCT activity is required for cell cycle
progression as indicated by the observation that maximal CCT protein and mRNA
levels were observed at the G1-S transition (90, 105). Moreover, when CCT
holocomplex levels were reduced via siRNA, or CCT-substrate interactions were
slowed by the addition of an anti-CCT monoclonal antibody, progression through G1S was severely impaired (90). This data provides evidence for a model in which
PhLP2 participates in the folding of several essential CCT substrates especially actin,
tubulin, and proteins necessary for the G1-S transition.
PhLP2B binds 14-3-3 proteins
In mammals, there are two PhLP2 proteins, PhLP2A and PhLP2B, which
share 57% sequence homology, but differ in expression patterns (21, 27). PhLP2A is
ubiquitously expressed, but PhLP2B is only found in male and female germ-cells
undergoing meiotic maturation (27). The sequence similarities and spacial expression
differences led to the belief that PhLP2A and PhLP2B have parallel, albeit tissuespecific functions. PhLP2B was found to co-immunoprecipitate with 14-3-3 proteins
from mouse testicular protein extracts (27). 14-3-3 binding usually occurs at
consensus binding sites such as RSXS*XP, RX(Y/F)XS*XP (S* denotes a
phophoserine and X is any amino acid), or other similar sites (106). Therefore, it was
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proposed that 14-3-3 bound to the RSSVP motif, amino acids 119-123, of mouse
PhLP2B (27). In human PhLP2B, the 14-3-3 binding sequence is conserved as
RSSIP, amino acids 119-123, but human PhLP2A only retains the last two residues of
this sequence with no preceding serines so its ability to bind 14-3-3 was unknown.
Evidence for phosphorylation sites on PhLP2A
PhLP2A is an established phosphoprotein (28). Because it is a member of the
Pdc family, and Pdc activity is regulated by phosphorylation (36, 107), it was
hypothesized that PhLP2A folding function might also be regulated by
phosphorylation. The kinase CK2 phosphorylates serine or threonine residues that are
N-terminal to acidic amino acids usually found in the consensus sequence
S*/T*XXE/D. Several putative CK2 phosphorylation sites were identified in PhLP2A
using a ProSite scan. These sites are: S25, T47, T52, S98, T190, T206, S234, and
S236. A mouse proteome phosphorylation site database developed by Steven Gygi
and his lab found three empirical phosphorylation sites on mouse PhLP2A: S65,
S235, and S237 (108). The S65 site is not conserved in human PhLP2 proteins, but
S235 and S237 are conserved as S234 and S236 in human PhLP2A and PhLP2B.
This chapter explains how immunoprecipitation and mass spectrometry were
used to identify possible PhLP2A folding substrates and identify PhLP2A
phosphorylation sites. The immunoprecipitations shown in Figure 4-3 were done by
Amy J. Gray, and the phosphorylation site identification by mass spectrometry work
was done by Zhaoyuan Chen in collaboration with the laboratory of Dr. Craig Thulin.
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Experimental Procedures
Cell Culture
HEK 293T cells were cultured in Dulbecco’s modified Eagle’s medium/F-12
(50/50 mix) growth media with L-Glutamine and 15mM HEPES, supplemented with
10% fetal bovine serum (Sigma). The cells were subcultured regularly to maintain
active growth but were not used beyond 20-25 passages.
Preparation of cDNA Constructs
Human PhLP1, PhLP1-TEV, PhLP2A, PhLP2A-TEV, PhLP2B, PhLP3, 14-33-Flag, rat Pdc, and Pdc-TEV with 3′ c-myc and His6 tags were cloned into
pcDNA3.1/myc-His B vector (Invitrogen). The PhLP1 and rat Pdc constructs were
made as described (19). A TEV cleavage sequence (Glu-Asn-Leu-Tyr-Phe-Gln-Gly)
was added to the 3′ end of Pdc, PhLP1 and PhLP2A using PCR, and the sequences
were cloned into the pcDNA3.1/myc-His B vector’s multiple cloning site using the 5′
EcoRI and 3′ XbaI restriction sites for Pdc and PhLP1, and the 5′ BamHI and 3′ XbaI
sites for PhLP2A. Both the PhLP2B and PhLP3 sequences (Open Biosystems) were
cloned into the pcDNA3.1/myc-His B vector using the 5′ EcoRI and 3′ XbaI sites. All
Pdc family genes were cloned into the pcDNA3.1/myc-His B vector in frame with the
3′ myc-His6 vector sequence. A Flag-tag was added to 3′ end of the human 14-3-3ε
sequence (Open Biosystems) by PCR and the sequence was cloned into
pcDNA3.1/myc-His B via the 5′ EcoRI and 3′ XbaI sites. The human PhLP2A gene
was cloned into the pETDuet-1 vector (Novagen) at multiple cloning site 1 via the 5′
BamHI and 3′ HindIII sites in frame with the 5′ His6 tag. The integrity of each
construct was validated by automated DNA sequencing and analysis.

70

Transient Transfections
HEK 293T cells were plated in 6-well plates so that they were 70-80%
confluent the next day. The cells were then separately transfected with 1.0 μg of
empty vector, Pdc, PhLP1, PhLP2A, PhLP2B, or PhLP3 in pcDNA3.1/myc-His B
using Lipofectamine Plus Reagent according to the manufacturer’s protocol
(Invitrogen). For co-transfections involving 14-3-3ε and PhLP2A or transfections
involving 14-3-3ε or empty vector, 1.0 μg 14-3-3ε and 1.0 μg PhLP2A, or 1.0 μg 143-3ε or the empty vector each in pcDNA3.1/myc-His B were transfected using
Lipofectamine 2000 Reagent (Invitrogen) according to the manufacturer’s directions.
For transfections that were subsequently used for mass spec analysis, HEK
293T cells were plated in 60-mm dishes so that they were 70-80% confluent on the
next day. The cells were transfected with 2.5 μg each of empty vector, Pdc-TEV,
PhLP1-TEV, or PhLP2A-TEV in pcDNA3.1/myc-His B using Lipofectamine Plus
Reagent (Invitrogen). Twenty-four hours later, 2 ml of fresh media was added to each
well of the 6-well plate and 5 ml of media was added to each 60-mm dish. For all
transfections, the cells were used in subsequent immunoprecipitations 48 hours after
transfection.
Immunoprecipitation Experiments
Transfected HEK-293T cells were washed twice with phosphate-buffered
saline (PBS, Fisher) and solubilized in immunoprecipitation buffer (PBS, pH 7.4, 2%
Igepal (Sigma), 0.6 mM PMSF, and 6 μl mammalian protease inhibitor cocktail
(Sigma)/ml of buffer. The lysates were triterated 10-12 times through a 25 gauge
needle and centrifuged at maximum speed in an Eppendorf microfuge for 10 minutes
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at 4°C. The clarified lysates were incubated for 30 minutes at 4°C with 3.5 μg of antic-myc (clone 9E10, BioMol), or 7.5 μg anti-Flag (clone M2, Sigma), or 2.0 μg antiCCTε (PK/29/23/8d, AbD Serotec) antibody for lysates from a 6-well plate, and 8.75
μg of the same anti-myc antibody for lysates from a 60-mm dish. Twenty μl (6-well
plate) or 30 μl (60-mm dish) of a 50% slurry of Protein A/G Plus agarose (Santa Cruz
Biotechnology) was added to each sample and then incubated for an additional 30
minutes at 4°C. For immunoprecipitations used for immunoblotting, the precipitate
was solubilized in undiluted 4X SDS sample buffer, resolved on a 10% Tris-GlycineSDS gel, and then blotted onto nitrocellulose. The blots were probed using the anti-cmyc, anti-Flag, or anti-CCTε antibodies described above, or a rabbit polyclonal antiGβ1 antibody. Immunoblots were developed with the ECL Plus chemiluminescence
reagent (Amersham) and visualized with a Storm 860 phosphorimager or incubated
with a secondary antibody conjugated to an infrared dye and visualized using the LiCor Odyssey Infrared Imaging System.
Mass spec sample preparation
For immunoprecipitations used for mass spec analysis, the washed protein
A/G beads were resuspended in 150 μl AcTEV protease cleavage buffer with 30 units
AcTEV protease (Invitrogen) and incubated for 16 hours at 4°C to cleave PhLP2A
and co-immunoprecipitating proteins off the beads. Next, each supernatant was
reduced with DTT at a final concentration of 4 mM at 60°C for 15 minutes. After the
samples had cooled to room temperature, the proteins were alkylated by addition of
iodoacetamide at a final concentration of 10 mM and incubated at room temperature
for 15 minutes in the dark. The proteins were then acetone precipitated with Acetone-
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HCL (one drop HCL in 10 ml acetone) at a ratio of 9 parts Acetone-HCl to 1 part
sample and incubated at -80°C for 16 hours. The precipitated proteins were pelleted at
maximum speed in an Eppendorf microfuge for 20 minutes at 4°C. The supernatant
was removed, and the pelleted proteins dried at room temperature for 20 minutes with
the tube lying on its side to prevent dust contamination. The pellet was rehydrated in
20 μl of 8M urea and an additional 73 μl of 25 mM ammonium bicarbonate and 7 μg
sequencing grade modified trypsin (Promega) were added. The trypsin digest was
incubated for 20 hours at 37°C in a rocking oven and the reaction was quenched by
the addition of 1 μl 88% formic acid followed by water bath sonication for 20
minutes. The samples were stored at -20°C until they were used for mass spec
analysis.
Protein Expression and Purification
His6-PhLP2A in pETDuet-1 was transformed into Escherichia coli DE3 cells
by heat shock. The cells were grown overnight at 37°C in a shaker-incubator and then
His6-PhLP2A protein expression was induced by the addition of isopropyl β-D-1thiogalactopyranoside (IPTG) at a final concentration of 500 μM and cells were
grown for another 3 hours at 37°C. The expressed protein was purified using a Probond nickel chelate column (Invitrogen). The resulting purified protein was
exchanged into 20 mM HEPES, pH 7.2, 150 mM NaCl buffer using an Amicon Ultra
centrifuge concentrator (Millipore) and protein concentration was assayed using the
Coomassie Plus protein assay reagent (Pierce). The protein was stored with 50%
glycerol at -20°C.
CK2 Phosphorylation of PhLP2A
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PhLP2A was prepared as a non-phosphorylated sample and a CK2
phosphorylated sample. To phosphorylate PhLP2A, a 300 μg amount of purified
protein was phosphorylated by CK2 (10 units/μl, Calbiochem) in 20 mM HEPES, pH
7.5, 100 mM KCl, 20 mM NaCl, 5mM MgCl2, 5 mM dithiothreitol, and 1 mM ATP
for 1 hour at 37°C (36). The non-phosphorylated sample was treated with calf
intestinal alkaline phosphatase (1 unit/μl, Invitrogen) according to the manufacturer’s
instructions for 1 hour at 37°C to make sure that the non-phosphorylated sample
protein was completely non-phosphorylated. Both protein samples were digested with
sequencing grade modified trypsin for 20 hours at 37°C in a rocking oven.
TiO2 phosphopeptide enrichment
The phosphorylated PhLP2A peptides were enriched by running 10 μg of the
peptides through a MonoTip TiO Pipette Tip (GL Sciences) according to the
manufacturer’s instructions. The TiO2 microtip was preconditioned in acetonitrile,
conditioned in 0.2 M phosphate buffer, pH 7.0, and equilibrated in a 50% aqueous
acetonitrile solution with 1% formic acid. The phosphopeptides were adsorbed to the
matrix by pipeting 20 times through the tip. Non-phosphorylated peptides were rinsed
off the matrix using a 50% aqueous acetonitrile solution with 0.1% formic acid and
0.1 M KCl, and phosphopeptides were eluted with 0.2 M phosphate buffer, pH 7.0.
Mass Spectrometric Analyses
Tryptic peptides from the Pdc family co-immunoprecipitations and in vitro
CK2 phosphorylated PhLP2A and non-phosphorylated samples were analyzed by
LCMSMS using an Applied Biosystems API Qstar Pulsar i quadrapole orthogonal
time-of –flight mass spectrometer with an online LC Packings (Dionex) UltiMaste
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Plus Capillary LC System and ionspray source. Tryptic digests of each protein sample
were run through a 15 cm x 250 μm-i.d. column hand-packed with Jupiter C18 10 μm
reverse phase resin (Phenomenex). An initial gradient of 2.2%/min to a concentration
of 60% acetonitrile in 0.1% formic acid was applied to the column, followed by a
3.5%/minute gradient up to a concentration of 95% organic phase. The HPLC was
controlled by the mass spectrometer software (Analyst, Applied Biosystems) and
incorporated into a FamOC autosampler (Dionex). The column effluent was analyzed
in an information-dependant acquisition (IDA) mode on the mass spectrometer. In
this mode, a survey scan (full MS scan) is performed and then the three most intense
peaks from the survey scan are automatically chosen for collision-induced
dissociation fragmentation to obtain an MSMS spectra, as long as they have not been
chosen for fragmentation in the last 2 min (time exclusion). Data were collected over
the 1 hour time course of the chromatogram and data collection and processing were
prepared using the Analyst QS software package (Applied Biosystems). For the Pdc
family binding-partner search, protein identifications were assigned using MASCOT
software found at www.matrixscience.com (Matrix Science) which searched both the
NCBInr and Swissprot databases. For phosphorylation site identification, the
reconstructed IDA spectra were searched in the MASCOT database with and without
an extra 80 Da or 98 Da corresponding respectively to phosphorylation or a neutral
loss of phosphoric acid. Molecular ions of m/z predicted for possible
phosphorylation sites were selected as parent ions in manual selection LCMSMS
experiments. CID spectra were compared with theoretical peptide fragments to
deduce specific phosphorylation sites.
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Results
PhLP2 proteins do not co-immunoprecipitate endogenous Gβ1 in human cells
Pdc and PhLP1 each contain an N-terminal Gβγ binding domain, but there are no Gβγ
binding domains present in PhLP2 proteins (21, 28). Flanary et al. showed that PhLP2
may be able to bind very weakly to Gβγ in yeast, but the results were questionable
due to the extremely long exposure time needed to identify Gβ in the immunoblot
(29). In order to investigate the Gβ1 binding capability of human PhLP2 proteins,
myc-tagged Pdc, PhLP1, PhLP2A, or PhLP2B were singly expressed with a Cterminal myc tag in HEK 293T cells.
Each Pdc family protein was
immunoprecipitated with an anti-myc
Figure 4-1. PhLP2 proteins do not
bind endogenous amounts of Gβ1.
HEK 293T cells were transfected
with 1μg of each indicated myctagged Pdc family genes in
pcDNA3.1 B+. After 48 hours, cell
lysates were immunoprecipitated
with an anti-myc antibody and
immunoblotted with an anti-Gβ1
antibody.

antibody, and then immunoblotted with
an anti-Gβ1 antibody. A representative
immunoblot is shown in Figure 4-1. As
expected, both Pdc-myc and PhLP1-myc
co-immunoprecipitated endogenous Gβ1
very well (107), but neither PhLP2

proteins were able to bind endogenous Gβ1 at all. This data indicates that the function
of the PhLP2 proteins is separate and unrelated to Gβγ signaling in human cells.
PhLP2 proteins bind CCT as well as PhLP1
PhLP2 is known to interact with the CCT holocomplex in yeast (58, 97, 98),
so it was hypothesized that PhLP2 might act as a co-chaperone with CCT in protein
folding akin to PhLP1. To investigate this hypothesis in human cells, PhLP2’s ability
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to co-immunoprecipitate CCTε
was tested. Pdc, PhLP1, PhLP2A,
PhLP2B, or PhLP3 were
separately expressed with a Cterminal myc tag in HEK 293T
Figure 4-2. All Pdc family proteins,
except Pdc, bind CCT.
HEK 293T cells were transfected with 1 μg
of each indicated myc-tagged Pdc family
genes in pcDNA3.1 B+. After 48 hours, cell
lysates were immunoprecipitated with an
anti-myc antibody and immunoblotted with
either an anti-CCTε antibody or an anti-myc
antibody .

cells. Each Pdc family protein was
immunoprecipitated with an antimyc antibody and the
immunoprecipitates were blotted
with either the anti-myc or a

monoclonal anti-CCTε antibody. It was clearly shown (Fig. 4-2) that all Pdc family
members, with the exception of Pdc, bind CCT with PhLP1 and PhLP2 binding
equally well. This data suggests that all human Pdc family proteins, except Pdc itself,
act as co-chaperones with CCT in protein folding.
A proteomics search for PhLP2A binding partners
To facilitate the identification of PhLP2A folding substrates, an
immunoprecipitation coupled with mass spectrometry strategy was employed. PdcTEV, PhLP1-TEV, PhLP2A-TEV, each with a C-terminal myc tag, or an empty
vector control, were expressed in HEK 293T cells. Each Pdc family member was
immunoprecipitated with an antibody against the myc tag and the samples were
incubated with TEV protease. This procedure freed the PhLP proteins and any
interacting partners from the antibody and protein A/G beads, removing these
contaminants from the mass spec analysis. The proteins were reduced, alkylated,
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acetone precipitated, and then digested with trypsin. The resulting peptides were
analyzed by LCMSMS and protein identifications assigned using the MASCOT
software found at www.matrixscience.com. The proteins listed in Table 4-1 were
found to interact with either the empty vector control, Pdc, PhLP1 or PhLP2A.
Proteins found in the PhLP2A sample that were also found in the Pdc or empty vector
controls were treated as false-positive identifications, except for 14-3-3ε which is a
known Pdc binding partner (109, 110). Several proteins, including elongation factor
1α (eEF1α), NADH-quinone reductase, and S-adenosylmethionine decarboxylase
proenzyme 1 were found to interact with PhLP1 and PhLP2A. Six of eight CCT
subunits were found in the PhLP2A sample, indicating that PhLP2A interacts with the
entire CCT holocomplex and not only with individual CCT subunits. Three proteins,
α-tubulin, 14-3-3γ, and ribosomal protein L3, were found to interact specifically with
PhLP2A, and not with the positive and negative controls.
PhLP2A and CCT both bind 14-3-3 epsilon
The PhLP2A-14-3-3 interaction identified by mass spec was further
substantiated by immunoprecipitation. Flag-tagged 14-3-3ε and myc-tagged PhLP2A
were co-expressed in HEK 293T cells and each protein was able to
immunoprecipitate the other (Figure 4-3A). Clearly, 14-3-3 and PhLP2A were able
to associate despite the fact that PhLP2A does not contain a consensus 14-3-3 binding
site. This observation led to the belief that 14-3-3 might also associate with CCT. To
test this hypothesis, Flag-tagged 14-3-3ε or an empty vector control were expressed
separately in HEK 293T cells. In each sample, endogenous CCTε was
immunoprecipitated, and 14-3-3ε was found in the CCT co-immunoprecipitate
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Identified Protein
Contaminants
Bovine albumin
TEV protease
Trypsin
Non-specific interactors
β-actin
α-actinin 1
ATP synthase β subunit
Cobalamin synthesis protein
HSP 60
HSP 70
PhLP1 and 2A interactors
CCTα
CCTγ
CCTη
Elongation factor 1α
NADH-quinone reductase
S-adenosylmet. decarboxylase
PhLP2A specific interactors
CCTβ
CCTδ
CCTθ
14-3-3ε
14-3-3γ
α-tubulin
Ribosomal protein L3

Bait Protein
Pdc
PhLP1
132
90
117

vector
244
99
54

78
80
96
50
90
125

40

29

164

44

PhLP2A
112
118

111
40

78
79
83
50
66
62

76
64
99
67
44
45

64
80
196
65
39
37
83
32
60
59
60
45
46

Table 4-1. Pdc family binding partners identified in a mass spec
analysis.
HEK 293 cells were transfected with an empty vector control, Pdc-TEV,
PhLP1-TEV, or PhLP2A-TEV all with a C-terminal myc tag in pcDNA
3.1 B+. After 48 hours, cells were lysed and immunoprecipitated with an
anti-myc antibody. PhLP2A and co-immunoprecipitating proteins were
cleaved from Protein A/G beads using a TEV protease. Proteins were
then reduced, alkylated, precipitated with acetone, and digested with
trypsin. LCMSMS was performed on each sample and each spectra sent
to MASCOT. Each protein is listed with its assigned MOWSE (molecular
weight search) score which is a weighted probability score based on
peptide masses and fragment ions (theoretical values vs. experimental
data). Higher MOWSE scores indicate greater confidence in the protein
identification. Only those scores with p values <0.05 are listed.
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(Figure 4-3B). These findings

in human cells.
PhLP2A phosphorylation site

Blot:
Flag-14-3-3ε

anti-Flag-14-3-3ε

associate with both PhLP2A and CCT

Lysate

indicate that 14-3-3 is able to

anti-myc-PhLP2A

IP:

A.

empty
vector

Flag-14-3-3ε

Blot:
Myc-PhLP2A

identification

B.

In order to learn more about

IP: CCTε
CCTε

PhLP2A, phosphorylation site

Flag-14-3-3ε

identification (PSI) via mass

Lysate
Flag-14-3-3ε

spectrometry was used. PhLP2A was
cloned into pETDuet-1 bacterial
expression vector in frame with the
vector’s N-terminal His tag. The
protein was expressed in E. coli, and
purified over a nickel chelate column.
The purified His-PhLP2A protein was
divided into two samples and the first
sample was CK2 phosphorylated
while the other was dephosphorylated
with calf intestinal alkaline
phosphatase to act as a non-

Figure 4-3. PhLP2A and CCT
bind 14-3-3ε.
HEK 293T cells were treated as
follows. A) Cells were transfected
with 1 μg of each Flag-14-3-3ε and
PhLP2A-myc in pcDNA3.1(+)/mycHis. After 48 hours, the cell lysate was
divided in half. One half was
immunoprecipitated with an anti-Flag
antibody and the other half was
immunoprecipitated with an anti-myc
antibody. Each immunoprecipitation
was blotted with either the anti-Flag
antibody for 14-3-3ε or the anti-myc
antibody for PhLP2A. B) Cells were
transfected with 1µg of either Flag-143-3ε in pcDNA3.1(+)/myc-His or the
empty vector control. After 48 hours,
the cells were lysed,
immunoprecipitated with an anti-CCTε
antibody, and then immunoblotted with
the anti-CCTε antibody or an anti-Flag
antibody for 14-3-3ε. Ten micrograms
of total cell lysate was blotted with an
anti-Flag antibody for 14-3-3ε.

phosphorylated control. Both protein
samples were digested with trypsin and the phosphorylated sample was enriched for
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phosphopeptides using a TiO2 microtip. The TiO2 microtip is positively charged and
attracts the negatively charged phosphate groups yielding an eluant which contains a
higher percentage of phosphopeptides, thereby increasing the likelihood of
phosphorylation site identification. Each sample was analyzed by LCMSMS and
peptide identities were assigned by MASCOT. When the phosphorylated sample
spectra were sent to MASCOT, the program indicated that T52 on tryptic peptide 8
was phosphorylated. The monoisotopic masses of peptide 8 were 2996.1 and 2916.1
for the phosphorylated and non-phosphorylated peptide, respectively (Fig. 4-4 A and
B). This mass difference of 80 Da indicated that this peptide was singly
phosphorylated in this analysis. The y-series in the MSMS spectra for both samples
was the same until T52 which indicated that T52 was the phosphorylated amino acid.
The same tryptic peptide was identified in a subsequent LCMSMS run with evidence

Figure 4-4A. MS and MSMS spectra from non-phosphorylated PhLP2A .
MS spectrum shows tryptic peptide 8, T8, (m/z = 973.4, +3 charge state) which had a
monoisotoptic mass of 2916.1 and eluted from time 17.175 to 17.857 minutes. MSMS
spectrum shows ions from the b and y series.
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Figure 4-4B. MS and MSMS spectra from T52 phosphorylated PhLP2A.
MS spectrum shows tryptic peptide 8, T8, (m/z = 1000.0, +3 charge state) which had a
monoisotopic mass of 2996.11 and eluted at time 17.62 minutes. MSMS spectrum shows
ions from the b and y series. The phosphorylated peptide’s mass is 80 Da greater than the
non-phosphorylated peptide indicating to a singly phosphorylated peptide. The y series
ions matches the non-phosphorylated y ions up until T52 which MASCOT identified as a
phosphothreonine.

of a single phosphorylation site at T47. The MSMS spectra showed a neutral loss of
phosphoric acid in the b-ion series, starting at b1, in the phosphorylated sample
indicating that T47 had been phosphorylated before collision induced dissociation
fragmentation (Fig 4-4C). MS data could not be obtained for all tryptic peptides, but
a good percentage, 75%, of the amino acids in PhLP2A were covered in the
phosphorylated sample. Unfortunately, no MS data was gathered for the most Cterminal peptide, DSDSEGD, in the phosphorylated sample so no phosphorylation
data was obtained for these two serines that were phosphorylated in the mouse screen.
The MASCOT search for both samples showed that E. coli elongation factor Tu (EF82

Figure 4-4C. MS and MSMS spectra from T47 phosphorylated PhLP2A .
MS spectrum shows tryptic peptide 8, T8, (m/z = 1000.0, +3 charge state) which had a
monoisotoptic mass of 2996.11 and eluted at time 16.64 minutes. MSMS spectrum shows
ions from the b and y series. The phosphorylated peptide’s mass is 80 Da greater than the
non-phosphorylated peptide indicating a singly phosphorylated peptide. The b series
indicates the loss of a phosphate group at T47.

Tu) was present in the nickel-purified PhLP2A samples and was assigned a MOWSE
score of 1302 in the nonphosphorylated sample and 876 in the phosphorylated
sample when a score of 60 was significant with p<0.05. Consequently, both scores
were highly significant indicating that EF-Tu purified with His-PhLP2A. Since
bacterial EF-Tu and eukaryotic eEF1α are homologous proteins, this identification is
consistent with the eEF1α identified in mammalian cells.

Discussion
This data proved that human PhLP2A and PhLP2B were not able to bind
endogenous Gβ1 in mammalian cells; an observation in agreement with that seen in
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yeast where the PhLP2-Gβγ interaction was extremely weak (29). Together, these
findings expand the thinking about the functions of Pdc family proteins and leads to a
belief that Pdc family members participate in functions other than G protein
signaling. A more unifying Pdc family attribute is the ability to act as cochaperones
with CCT in protein folding. The data herein established that human PhLP2A was
able to associate with CCT to the same extent as PhLP1 lending much credibility to
the hypothesis that PhLP2 acts as a CCT co-chaperone.
In previous studies, loss of optimal PhLP2A or CCT function due to
temperature sensitive mutants or protein knockdown led to some overlapping
consequences such as actin, tubulin, and cell cycle defects. Recently, the list of
possible CCT substrates has grown to include proteins involved in DNA replication,
mitosis, meiosis, RNA processing, transcription, translation, and signal transduction
(48, 90). Since both PhLP2 and CCT temperature sensitive mutants stall in the G1-S
phase transition, their folding functions must be required to promote entry into S
phase. During G1, the cell must dramatically increase its mass and volume via
protein synthesis to prepare for entry into S phase. In order to support the high level
of protein synthesis, elevated amounts of proteins and RNA involved in translation,
ribosome synthesis, and tRNA metabolism/charging are present (111). In fact,
downregulation of 270 out of 773 essential yeast genes (35%) caused a delay in G1-S
transition with nearly all of these genes playing some role in protein synthesis (111).
Logically, the need for protein folding and assembly increases directly with increased
translation. The model that PhLP2 and CCT work together in protein folding makes
sense given that phlp2-ts mutants or CCT knockdown cause a delay at the G1-S
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transition. However, a model in which PhLP2 only assists CCT in actin and tubulin
folding is too limited given that the prefoldin complex, which acts as a cochaperone
with CCT in the folding of actin and tubulin, is not an essential protein complex. Loss
of prefoldin function in yeast only led to a reduction in actin and tubulin folding
efficiency and a phenotype which exhibited slowed growth (51, 112). Since loss of
PhLP2 leads to cell death instead of merely slowed growth, it is hypothesized that
PhLP2A plays a key role with CCT in folding essential proteins necessary for the G1S transition that cannot be fully compensated by other chaperones.
Consequently, the identified PhLP2A interactions with 14-3-3ε, 14-3-3γ,
ribosomal protein L3, elongation factor 1α (eEF1α), and EF-Tu may be important for
entry into S phase because each of these proteins is known to play some role in the
cell cycle. The other identified interaction between PhLP2A and α-tubulin further
demonstrates that PhLP2A may play a role in tubulin folding and proves that PhLP2A
and α-tubulin interact in vivo. Even though these mass spec identifications were not
able lead to a specific PhLP2A function, they provide some clues that may lead to
that discovery.
14-3-3 proteins are highly conserved essential proteins found in all eukaryotes
which modulate many processes including cell cycle control and apoptosis. On the
molecular level, 14-3-3 proteins bind to specific phosphorylated sequences on many
proteins to induce conformational changes or manipulate protein-protein interactions
(113). Two 14-3-3 isoforms were found in association with PhLP2A, but oddly,
PhLP2A does not contain any consensus 14-3-3 binding sites. A small percentage of
non-phosphorylated proteins are able to bind 14-3-3s (114), but perhaps rather than
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binding to PhLP2A alone, 14-3-3 proteins bind to the PhLP2A-CCT complex to be
folded, dimerize, or modulate the folding of other proteins.
Two homologous proteins known to participate in translational elongation,
bacterial elongation factor Tu (EF-Tu) and mammalian elongation factor 1α (eEF1α),
were found as PhLP2A binding partners. During elongation, the GTP-bound form of
eEF1α transports aminoacyl-tRNAs to the empty ribosomal A site. Upon GTP
hydrolysis, eEF1α is released from the ribosome, the nascent polypeptide is
transferred from the P site to the A site aminoacyl-tRNA, and an amino acid is added
to the polypeptide (115). Next, the mRNA translocates along the ribosome with the
assistance of elongation factor 2 (eEF2) so that a new codon is present in the A site
(116). Elongation factor binding and release from the ribosome is coordinated by
ribosomal protein L3 which binds separately to eEF1α and eEF2 and assists in their
sequential ribosome binding (117). The structure of eEF1α is predicted to be similar
to EF-Tu which consists of a GTPase domain and two β-barrel domains. As well, the
structure of eEF2 is comparable to the eEF1α-tRNA structure and consists of a six
domains including a GTPase domain and a β-barrel domain analogous to those of
eEF1α. Whereas this study found eEF1α and ribosomal protein L3 bound to PhLP2A
in vivo, Yam and colleagues determined that eEF2 interacted with CCT in vitro (48).
Both elongation factors contain at least one β-barrel domain which may be
aggregation prone due to its high β-sheet content. Perhaps the folding of these
elongation factors and assembly with ribosomal protein L3 is mediated by PhLP2A
and CCT. Elongation factors and ribosomal proteins are essential in protein synthesis
so their loss or misfolding would be congruent with G1-S arrest.
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The exact folding function of PhLP2A is not yet known, but it is probably
regulated by phosphorylation given the essential role of CK2 phosphorylation of
PhLP1 in Gβ folding and assembly with Gγ (36). Two phosphothreonine residues
were identified, T52 and T47. Both phosphorylation sites were identified on tryptic
peptide #8, T*YEDMT*LEELEDHEDEFNEEDER. There are probably other CK2
phosphorylation sites within human PhLP2A, especially at its C-terminus, but they
were not identified by this method. The reason for that may be because TiO2
microtips tend to bind negatively charged phosphorylated peptides as well as acidic
peptides. Both T52 and T47 were found on an acidic peptide with 13 acidic residues
out of 23 total residues. The additional phosphate group as well as the acidic nature of
the peptide may have led to this peptide’s preferential binding to the TiO2 column and
therefore this peptide may have been enriched to a greater degree than other peptides.
In the future, a different, but complementary phosphopeptide enrichment technique
may be used in order to enrich the sample for other phosphopeptides.
In conclusion, this work suggests that PhLP2A is a co-chaperone with CCT in
the folding of a possible subset of cytoskeletal and G1-S promoting proteins. In the
future, it will be interesting to positively identify the essential folding function of the
PhLP2A-CCT interaction.

87

REFERENCES
1.
2.
3.
4.

5.
6.
7.
8.
9.
10.
11.

12.
13.
14.

15.

Rockman, H. A., Koch, W. J., and Lefkowitz, R. J. (2002) Seventransmembrane-spanning receptors and heart function, Nature 415, 206-212.
Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., and Caron,
M. G. (2004) Desensitization of G protein-coupled receptors and neuronal
functions, Annu Rev Neurosci 27, 107-144.
Arshavsky, V. Y., Lamb, T. D., and Pugh, E. N., Jr. (2002) G proteins and
phototransduction, Annu Rev Physiol 64, 153-187.
Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J. P.,
Davenport, A. P., Spedding, M., and Harmar, A. J. (2005) International Union
of Pharmacology. XLVI. G protein-coupled receptor list, Pharmacol Rev 57,
279-288.
Simonds, W. F. (2003) G protein-regulated signaling dysfunction in human
disease, J Investig Med 51, 194-214.
Schoneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Rompler, H., and
Sangkuhl, K. (2004) Mutant G-protein-coupled receptors as a cause of human
diseases, Pharmacol Ther 104, 173-206.
Cabrera-Vera, T. M., Vanhauwe, J., Thomas, T. O., Medkova, M., Preininger,
A., Mazzoni, M. R., and Hamm, H. E. (2003) Insights into G protein structure,
function, and regulation, Endocr Rev 24, 765-781.
Neubig, R. R., and Siderovski, D. P. (2002) Regulators of G-protein signalling
as new central nervous system drug targets, Nat Rev Drug Discov 1, 187-197.
DeWire, S. M., Ahn, S., Lefkowitz, R. J., and Shenoy, S. K. (2007) Betaarrestins and cell signaling, Annu Rev Physiol 69, 483-510.
Ross, E. M., and Wilkie, T. M. (2000) GTPase-activating proteins for
heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGSlike proteins, Annu Rev Biochem 69, 795-827.
Krispel, C. M., Chen, D., Melling, N., Chen, Y. J., Martemyanov, K. A.,
Quillinan, N., Arshavsky, V. Y., Wensel, T. G., Chen, C. K., and Burns, M. E.
(2006) RGS expression rate-limits recovery of rod photoresponses, Neuron
51, 409-416.
Bauer, P. H., Muller, S., Puzicha, M., Pippig, S., Obermaier, B., Helmreich, E.
J., and Lohse, M. J. (1992) Phosducin is a protein kinase A-regulated Gprotein regulator, Nature 358, 73-76.
Lee, R. H., Lieberman, B. S., and Lolley, R. N. (1987) A novel complex from
bovine visual cells of a 33,000-dalton phosphoprotein with beta- and gammatransducin: purification and subunit structure, Biochemistry 26, 3983-3990.
Lee, R. H., Ting, T. D., Lieberman, B. S., Tobias, D. E., Lolley, R. N., and
Ho, Y. K. (1992) Regulation of retinal cGMP cascade by phosducin in bovine
rod photoreceptor cells. Interaction of phosducin and transducin, J Biol Chem
267, 25104-25112.
Yoshida, T., Willardson, B. M., Wilkins, J. F., Jensen, G. J., Thornton, B. D.,
and Bitensky, M. W. (1994) The phosphorylation state of phosducin

88

16.
17.
18.

19.
20.

21.

22.
23.
24.

25.
26.
27.

28.

determines its ability to block transducin subunit interactions and inhibit
transducin binding to activated rhodopsin, J Biol Chem 269, 24050-24057.
Barhite, S., Thibault, C., and Miles, M. F. (1998) Phosducin-like protein
(PhLP), a regulator of G beta gamma function, interacts with the proteasomal
protein SUG1, Biochim Biophys Acta 1402, 95-101.
McLaughlin, J. N., Thulin, C. D., Bray, S. M., Martin, M. M., Elton, T. S.,
and Willardson, B. M. (2002) Regulation of angiotensin II-induced G protein
signaling by phosducin-like protein, J Biol Chem 277, 34885-34895.
Humrich, J., Bermel, C., Bunemann, M., Harmark, L., Frost, R., Quitterer, U.,
and Lohse, M. J. (2005) Phosducin-like protein regulates G-protein
betagamma folding by interaction with tailless complex polypeptide-1alpha:
dephosphorylation or splicing of PhLP turns the switch toward regulation of
Gbetagamma folding, J Biol Chem 280, 20042-20050.
Lukov, G. L., Hu, T., McLaughlin, J. N., Hamm, H. E., and Willardson, B. M.
(2005) Phosducin-like protein acts as a molecular chaperone for G protein
betagamma dimer assembly, EMBO J 24, 1965-1975.
Sokolov, M., Strissel, K. J., Leskov, I. B., Michaud, N. A., Govardovskii, V.
I., and Arshavsky, V. Y. (2004) Phosducin facilitates light-driven transducin
translocation in rod photoreceptors. Evidence from the phosducin knockout
mouse, J Biol Chem 279, 19149-19156.
Blaauw, M., Knol, J. C., Kortholt, A., Roelofs, J., Ruchira, Postma, M.,
Visser, A. J., and van Haastert, P. J. (2003) Phosducin-like proteins in
Dictyostelium discoideum: implications for the phosducin family of proteins,
EMBO J 22, 5047-5057.
Savage, J. R., McLaughlin, J. N., Skiba, N. P., Hamm, H. E., and Willardson,
B. M. (2000) Functional roles of the two domains of phosducin and
phosducin-like protein, J Biol Chem 275, 30399-30407.
Thibault, C., Sganga, M. W., and Miles, M. F. (1997) Interaction of
phosducin-like protein with G protein betagamma subunits, J Biol Chem 272,
12253-12256.
Reig, J. A., Yu, L., and Klein, D. C. (1990) Pineal transduction. Adrenergic---cyclic AMP-dependent phosphorylation of cytoplasmic 33-kDa protein
(MEKA) which binds beta gamma-complex of transducin, J Biol Chem 265,
5816-5824.
Miles, M. F., Barhite, S., Sganga, M., and Elliott, M. (1993) Phosducin-like
protein: an ethanol-responsive potential modulator of guanine nucleotidebinding protein function, Proc Natl Acad Sci U S A 90, 10831-10835.
Schroder, S., and Lohse, M. J. (2000) Quantification of the tissue levels and
function of the G-protein regulator phosducin-like protein (PhlP), Naunyn
Schmiedebergs Arch Pharmacol 362, 435-439.
Lopez, P., Yaman, R., Lopez-Fernandez, L. A., Vidal, F., Puel, D., Clertant,
P., Cuzin, F., and Rassoulzadegan, M. (2003) A novel germ line-specific gene
of the phosducin-like protein (PhLP) family. A meiotic function conserved
from yeast to mice, J Biol Chem 278, 1751-1757.
Wilkinson, J. C., Richter, B. W., Wilkinson, A. S., Burstein, E., Rumble, J.
M., Balliu, B., and Duckett, C. S. (2004) VIAF, a conserved inhibitor of
89

29.
30.
31.

32.
33.
34.

35.
36.

37.
38.

39.

apoptosis (IAP)-interacting factor that modulates caspase activation, J Biol
Chem 279, 51091-51099.
Flanary, P. L., DiBello, P. R., Estrada, P., and Dohlman, H. G. (2000)
Functional analysis of Plp1 and Plp2, two homologues of phosducin in yeast,
J Biol Chem 275, 18462-18469.
Lacefield, S., and Solomon, F. (2003) A novel step in beta-tubulin folding is
important for heterodimer formation in Saccharomyces cerevisiae, Genetics
165, 531-541.
Stirling, P. C., Cuellar, J., Alfaro, G. A., El Khadali, F., Beh, C. T., Valpuesta,
J. M., Melki, R., and Leroux, M. R. (2006) PhLP3 modulates CCT-mediated
actin and tubulin folding via ternary complexes with substrates, J Biol Chem
281, 7012-7021.
Gaudet, R., Bohm, A., and Sigler, P. B. (1996) Crystal structure at 2.4
angstroms resolution of the complex of transducin betagamma and its
regulator, phosducin, Cell 87, 577-588.
Schroder, S., and Lohse, M. J. (1996) Inhibition of G-protein betagammasubunit functions by phosducin-like protein, Proc Natl Acad Sci U S A 93,
2100-2104.
Garzon, J., Rodriguez-Diaz, M., Lopez-Fando, A., Garcia-Espana, A., and
Sanchez-Blazquez, P. (2002) Glycosylated phosducin-like protein long
regulates opioid receptor function in mouse brain, Neuropharmacology 42,
813-828.
Thulin, C. D., Howes, K., Driscoll, C. D., Savage, J. R., Rand, T. A., Baehr,
W., and Willardson, B. M. (1999) The immunolocalization and divergent
roles of phosducin and phosducin-like protein in the retina, Mol Vis 5, 40.
Lukov, G. L., Baker, C. M., Ludtke, P. J., Hu, T., Carter, M. D., Hackett, R.
A., Thulin, C. D., and Willardson, B. M. (2006) Mechanism of assembly of G
protein betagamma subunits by protein kinase CK2-phosphorylated
phosducin-like protein and the cytosolic chaperonin complex, J Biol Chem
281, 22261-22274.
Kasahara, S., Wang, P., and Nuss, D. L. (2000) Identification of bdm-1, a
gene involved in G protein beta-subunit function and alpha-subunit
accumulation, Proc Natl Acad Sci U S A 97, 412-417.
McLaughlin, J. N., Thulin, C. D., Hart, S. J., Resing, K. A., Ahn, N. G., and
Willardson, B. M. (2002) Regulatory interaction of phosducin-like protein
with the cytosolic chaperonin complex, Proc Natl Acad Sci U S A 99, 79627967.
Gavin, A. C., Bosche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A.,
Schultz, J., Rick, J. M., Michon, A. M., Cruciat, C. M., Remor, M., Hofert, C.,
Schelder, M., Brajenovic, M., Ruffner, H., Merino, A., Klein, K., Hudak, M.,
Dickson, D., Rudi, T., Gnau, V., Bauch, A., Bastuck, S., Huhse, B., Leutwein,
C., Heurtier, M. A., Copley, R. R., Edelmann, A., Querfurth, E., Rybin, V.,
Drewes, G., Raida, M., Bouwmeester, T., Bork, P., Seraphin, B., Kuster, B.,
Neubauer, G., and Superti-Furga, G. (2002) Functional organization of the
yeast proteome by systematic analysis of protein complexes, Nature 415, 141147.
90

40.

41.
42.
43.

44.
45.

46.
47.
48.

49.
50.
51.

Ho, Y., Gruhler, A., Heilbut, A., Bader, G. D., Moore, L., Adams, S. L.,
Millar, A., Taylor, P., Bennett, K., Boutilier, K., Yang, L., Wolting, C.,
Donaldson, I., Schandorff, S., Shewnarane, J., Vo, M., Taggart, J.,
Goudreault, M., Muskat, B., Alfarano, C., Dewar, D., Lin, Z., Michalickova,
K., Willems, A. R., Sassi, H., Nielsen, P. A., Rasmussen, K. J., Andersen, J.
R., Johansen, L. E., Hansen, L. H., Jespersen, H., Podtelejnikov, A., Nielsen,
E., Crawford, J., Poulsen, V., Sorensen, B. D., Matthiesen, J., Hendrickson, R.
C., Gleeson, F., Pawson, T., Moran, M. F., Durocher, D., Mann, M., Hogue,
C. W., Figeys, D., and Tyers, M. (2002) Systematic identification of protein
complexes in Saccharomyces cerevisiae by mass spectrometry, Nature 415,
180-183.
Leroux, M. R., and Hartl, F. U. (2000) Protein folding: versatility of the
cytosolic chaperonin TRiC/CCT, Curr Biol 10, R260-264.
Valpuesta, J. M., Martin-Benito, J., Gomez-Puertas, P., Carrascosa, J. L., and
Willison, K. R. (2002) Structure and function of a protein folding machine:
the eukaryotic cytosolic chaperonin CCT, FEBS Lett 529, 11-16.
Llorca, O., McCormack, E. A., Hynes, G., Grantham, J., Cordell, J.,
Carrascosa, J. L., Willison, K. R., Fernandez, J. J., and Valpuesta, J. M.
(1999) Eukaryotic type II chaperonin CCT interacts with actin through
specific subunits, Nature 402, 693-696.
Hynes, G. M., and Willison, K. R. (2000) Individual subunits of the
eukaryotic cytosolic chaperonin mediate interactions with binding sites
located on subdomains of beta-actin, J Biol Chem 275, 18985-18994.
Llorca, O., Martin-Benito, J., Grantham, J., Ritco-Vonsovici, M., Willison, K.
R., Carrascosa, J. L., and Valpuesta, J. M. (2001) The 'sequential allosteric
ring' mechanism in the eukaryotic chaperonin-assisted folding of actin and
tubulin, EMBO J 20, 4065-4075.
Melki, R., Batelier, G., Soulie, S., and Williams, R. C., Jr. (1997) Cytoplasmic
chaperonin containing TCP-1: structural and functional characterization,
Biochemistry 36, 5817-5826.
Thulasiraman, V., Yang, C. F., and Frydman, J. (1999) In vivo newly
translated polypeptides are sequestered in a protected folding environment,
EMBO J 18, 85-95.
Yam, A. Y., Xia, Y., Lin, H. T., Burlingame, A., Gerstein, M., and Frydman,
J. (2008) Defining the TRiC/CCT interactome links chaperonin function to
stabilization of newly made proteins with complex topologies, Nat Struct Mol
Biol 15, 1255-1262.
Farr, G. W., Scharl, E. C., Schumacher, R. J., Sondek, S., and Horwich, A. L.
(1997) Chaperonin-mediated folding in the eukaryotic cytosol proceeds
through rounds of release of native and nonnative forms, Cell 89, 927-937.
Camasses, A., Bogdanova, A., Shevchenko, A., and Zachariae, W. (2003) The
CCT chaperonin promotes activation of the anaphase-promoting complex
through the generation of functional Cdc20, Mol Cell 12, 87-100.
Siegers, K., Bolter, B., Schwarz, J. P., Bottcher, U. M., Guha, S., and Hartl, F.
U. (2003) TRiC/CCT cooperates with different upstream chaperones in the
folding of distinct protein classes, EMBO J 22, 5230-5240.
91

52.

53.

54.
55.
56.
57.

58.

59.
60.
61.
62.
63.

64.
65.

Martin-Benito, J., Bertrand, S., Hu, T., Ludtke, P. J., McLaughlin, J. N.,
Willardson, B. M., Carrascosa, J. L., and Valpuesta, J. M. (2004) Structure of
the complex between the cytosolic chaperonin CCT and phosducin-like
protein, Proc Natl Acad Sci U S A 101, 17410-17415.
Martin-Benito, J., Boskovic, J., Gomez-Puertas, P., Carrascosa, J. L., Simons,
C. T., Lewis, S. A., Bartolini, F., Cowan, N. J., and Valpuesta, J. M. (2002)
Structure of eukaryotic prefoldin and of its complexes with unfolded actin and
the cytosolic chaperonin CCT, EMBO J 21, 6377-6386.
Knol, J. C., Engel, R., Blaauw, M., Visser, A. J., and van Haastert, P. J. (2005)
The phosducin-like protein PhLP1 is essential for G{beta}{gamma} dimer
formation in Dictyostelium discoideum, Mol Cell Biol 25, 8393-8400.
Wells, C. A., Dingus, J., and Hildebrandt, J. D. (2006) Role of the chaperonin
CCT/TRiC complex in G protein betagamma-dimer assembly, J Biol Chem
281, 20221-20232.
Humrich, J., Bermel, C., Grubel, T., Quitterer, U., and Lohse, M. J. (2003)
Regulation of phosducin-like protein by casein kinase 2 and N-terminal
splicing, J Biol Chem 278, 4474-4481.
Dupre, D. J., Robitaille, M., Richer, M., Ethier, N., Mamarbachi, A. M., and
Hebert, T. E. (2007) Dopamine receptor-interacting protein 78 acts as a
molecular chaperone for Ggamma subunits before assembly with Gbeta, J
Biol Chem 282, 13703-13715.
Stirling, P. C., Srayko, M., Takhar, K. S., Pozniakovsky, A., Hyman, A. A.,
and Leroux, M. R. (2007) Functional interaction between phosducin-like
protein 2 and cytosolic chaperonin is essential for cytoskeletal protein
function and cell cycle progression, Mol Biol Cell 18, 2336-2345.
Ogawa, S., Matsubayashi, Y., and Nishida, E. (2004) An evolutionarily
conserved gene required for proper microtubule architecture in Caenorhabditis
elegans, Genes Cells 9, 83-93.
Wettschureck, N., and Offermanns, S. (2005) Mammalian G proteins and their
cell type specific functions, Physiol Rev 85, 1159-1204.
Farrens, D. L., Altenbach, C., Yang, K., Hubbell, W. L., and Khorana, H. G.
(1996) Requirement of rigid-body motion of transmembrane helices for light
activation of rhodopsin, Science 274, 768-770.
Li, J., Edwards, P. C., Burghammer, M., Villa, C., and Schertler, G. F. (2004)
Structure of bovine rhodopsin in a trigonal crystal form, J Mol Biol 343, 14091438.
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox,
B. A., Le Trong, I., Teller, D. C., Okada, T., Stenkamp, R. E., Yamamoto, M.,
and Miyano, M. (2000) Crystal structure of rhodopsin: A G protein-coupled
receptor, Science 289, 739-745.
Reiter, E., and Lefkowitz, R. J. (2006) GRKs and beta-arrestins: roles in
receptor silencing, trafficking and signaling, Trends Endocrinol Metab 17,
159-165.
Willars, G. B. (2006) Mammalian RGS proteins: multifunctional regulators of
cellular signalling, Semin Cell Dev Biol 17, 363-376.

92

66.
67.
68.
69.
70.
71.
72.
73.
74.
75.

76.
77.
78.

79.
80.
81.

Marrari, Y., Crouthamel, M., Irannejad, R., and Wedegaertner, P. B. (2007)
Assembly and trafficking of heterotrimeric G proteins, Biochemistry 46, 76657677.
Kubota, S., Kubota, H., and Nagata, K. (2006) Cytosolic chaperonin protects
folding intermediates of Gbeta from aggregation by recognizing hydrophobic
beta-strands, Proc Natl Acad Sci U S A 103, 8360-8365.
Gautam, N., Downes, G. B., Yan, K., and Kisselev, O. (1998) The G-protein
betagamma complex, Cell Signal 10, 447-455.
Robishaw, J. D., and Berlot, C. H. (2004) Translating G protein subunit
diversity into functional specificity, Curr Opin Cell Biol 16, 206-209.
Watson, A. J., Katz, A., and Simon, M. I. (1994) A fifth member of the
mammalian G-protein beta-subunit family. Expression in brain and activation
of the beta 2 isotype of phospholipase C, J Biol Chem 269, 22150-22156.
Downes, G. B., and Gautam, N. (1999) The G protein subunit gene families,
Genomics 62, 544-552.
Myung, C. S., Lim, W. K., DeFilippo, J. M., Yasuda, H., Neubig, R. R., and
Garrison, J. C. (2006) Regions in the G protein gamma subunit important for
interaction with receptors and effectors, Mol Pharmacol 69, 877-887.
Ray, K., Hansen, C. A., and Robishaw, J. D. (1996) Gbetagamma-Mediated
Signaling in the Heart: Implications of beta and gamma Subunit
Heterogeneity, Trends Cardiovasc Med. 6, 115-121.
Jones, M. B., Siderovski, D. P., and Hooks, S. B. (2004) The
G{beta}{gamma} DIMER as a NOVEL SOURCE of SELECTIVITY in GProtein Signaling: GGL-ing AT CONVENTION, Mol Interv 4, 200-214.
Dingus, J., Wells, C. A., Campbell, L., Cleator, J. H., Robinson, K., and
Hildebrandt, J. D. (2005) G Protein betagamma dimer formation: Gbeta and
Ggamma differentially determine efficiency of in vitro dimer formation,
Biochemistry 44, 11882-11890.
Carter, M. D., Southwick, K., Lukov, G., Willardson, B. M., and Thulin, C. D.
(2004) Identification of phosphorylation sites on phosducin-like protein by
QTOF mass spectrometry, J Biomol Tech 15, 257-264.
Arshavsky, V. Y., and Pugh, E. N., Jr. (1998) Lifetime regulation of G
protein-effector complex: emerging importance of RGS proteins, Neuron 20,
11-14.
Dohlman, H. G., Song, J., Ma, D., Courchesne, W. E., and Thorner, J. (1996)
Sst2, a negative regulator of pheromone signaling in the yeast Saccharomyces
cerevisiae: expression, localization, and genetic interaction and physical
association with Gpa1 (the G-protein alpha subunit), Mol Cell Biol 16, 51945209.
Siderovski, D. P., Hessel, A., Chung, S., Mak, T. W., and Tyers, M. (1996) A
new family of regulators of G-protein-coupled receptors?, Curr Biol 6, 211212.
Siderovski, D. P., and Willard, F. S. (2005) The GAPs, GEFs, and GDIs of
heterotrimeric G-protein alpha subunits, Int J Biol Sci 1, 51-66.
Natochin, M., and Artemyev, N. O. (2000) Mutational analysis of functional
interfaces of transducin, Methods Enzymol 315, 539-554.
93

82.
83.
84.
85.
86.
87.

88.

89.
90.
91.
92.
93.

94.
95.
96.

Tesmer, J. J., Berman, D. M., Gilman, A. G., and Sprang, S. R. (1997)
Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the
transition state for GTP hydrolysis, Cell 89, 251-261.
Hu, G., and Wensel, T. G. (2002) R9AP, a membrane anchor for the
photoreceptor GTPase accelerating protein, RGS9-1, Proc Natl Acad Sci U S
A 99, 9755-9760.
Martemyanov, K. A., Yoo, P. J., Skiba, N. P., and Arshavsky, V. Y. (2005)
R7BP, a novel neuronal protein interacting with RGS proteins of the R7
family, J Biol Chem 280, 5133-5136.
Witherow, D. S., and Slepak, V. Z. (2003) A novel kind of G protein
heterodimer: the G beta5-RGS complex, Receptors Channels 9, 205-212.
Chen, C. K., Burns, M. E., He, W., Wensel, T. G., Baylor, D. A., and Simon,
M. I. (2000) Slowed recovery of rod photoresponse in mice lacking the
GTPase accelerating protein RGS9-1, Nature 403, 557-560.
Nishiguchi, K. M., Sandberg, M. A., Kooijman, A. C., Martemyanov, K. A.,
Pott, J. W., Hagstrom, S. A., Arshavsky, V. Y., Berson, E. L., and Dryja, T. P.
(2004) Defects in RGS9 or its anchor protein R9AP in patients with slow
photoreceptor deactivation, Nature 427, 75-78.
Zachariou, V., Georgescu, D., Sanchez, N., Rahman, Z., DiLeone, R., Berton,
O., Neve, R. L., Sim-Selley, L. J., Selley, D. E., Gold, S. J., and Nestler, E. J.
(2003) Essential role for RGS9 in opiate action, Proc Natl Acad Sci U S A
100, 13656-13661.
Cheever, M. L., Snyder, J. T., Gershburg, S., Siderovski, D. P., Harden, T. K.,
and Sondek, J. (2008) Crystal structure of the multifunctional Gbeta5-RGS9
complex, Nat Struct Mol Biol 15, 155-162.
Grantham, J., Brackley, K. I., and Willison, K. R. (2006) Substantial CCT
activity is required for cell cycle progression and cytoskeletal organization in
mammalian cells, Exp Cell Res 312, 2309-2324.
Kisselev, O., and Gautam, N. (1993) Specific interaction with rhodopsin is
dependent on the gamma subunit type in a G protein, J Biol Chem 268, 2451924522.
Fletcher, J. E., Lindorfer, M. A., DeFilippo, J. M., Yasuda, H., Guilmard, M.,
and Garrison, J. C. (1998) The G protein beta5 subunit interacts selectively
with the Gq alpha subunit, J Biol Chem 273, 636-644.
He, W., Lu, L., Zhang, X., El-Hodiri, H. M., Chen, C. K., Slep, K. C., Simon,
M. I., Jamrich, M., and Wensel, T. G. (2000) Modules in the photoreceptor
RGS9-1.Gbeta 5L GTPase-accelerating protein complex control effector
coupling, GTPase acceleration, protein folding, and stability, J Biol Chem
275, 37093-37100.
Jones, M. B., and Garrison, J. C. (1999) Instability of the G-protein beta5
subunit in detergent, Anal Biochem 268, 126-133.
Kunisawa, J., and Shastri, N. (2003) The group II chaperonin TRiC protects
proteolytic intermediates from degradation in the MHC class I antigen
processing pathway, Mol Cell 12, 565-576.
Wang, Y., and Dohlman, H. G. (2004) Pheromone signaling mechanisms in
yeast: a prototypical sex machine, Science 306, 1508-1509.
94

97.

98.

99.
100.
101.
102.
103.

104.
105.

106.
107.
108.
109.

Collins, S. R., Kemmeren, P., Zhao, X. C., Greenblatt, J. F., Spencer, F.,
Holstege, F. C., Weissman, J. S., and Krogan, N. J. (2007) Toward a
comprehensive atlas of the physical interactome of Saccharomyces cerevisiae,
Mol Cell Proteomics 6, 439-450.
Gavin, A. C., Aloy, P., Grandi, P., Krause, R., Boesche, M., Marzioch, M.,
Rau, C., Jensen, L. J., Bastuck, S., Dumpelfeld, B., Edelmann, A., Heurtier,
M. A., Hoffman, V., Hoefert, C., Klein, K., Hudak, M., Michon, A. M.,
Schelder, M., Schirle, M., Remor, M., Rudi, T., Hooper, S., Bauer, A.,
Bouwmeester, T., Casari, G., Drewes, G., Neubauer, G., Rick, J. M., Kuster,
B., Bork, P., Russell, R. B., and Superti-Furga, G. (2006) Proteome survey
reveals modularity of the yeast cell machinery, Nature 440, 631-636.
Spiess, C., Meyer, A. S., Reissmann, S., and Frydman, J. (2004) Mechanism
of the eukaryotic chaperonin: protein folding in the chamber of secrets, Trends
Cell Biol 14, 598-604.
Ghaemmaghami, S., Huh, W. K., Bower, K., Howson, R. W., Belle, A.,
Dephoure, N., O'Shea, E. K., and Weissman, J. S. (2003) Global analysis of
protein expression in yeast, Nature 425, 737-741.
McMillan, J. N., Sia, R. A., and Lew, D. J. (1998) A morphogenesis
checkpoint monitors the actin cytoskeleton in yeast, J Cell Biol 142, 14871499.
Ito, T., Chiba, T., Ozawa, R., Yoshida, M., Hattori, M., and Sakaki, Y. (2001)
A comprehensive two-hybrid analysis to explore the yeast protein
interactome, Proc Natl Acad Sci U S A 98, 4569-4574.
Wysocka, M., Rytka, J., and Kurlandzka, A. (2004) Saccharomyces cerevisiae
CSM1 gene encoding a protein influencing chromosome segregation in
meiosis I interacts with elements of the DNA replication complex, Exp Cell
Res 294, 592-602.
Stoldt, V., Rademacher, F., Kehren, V., Ernst, J. F., Pearce, D. A., and
Sherman, F. (1996) Review: the Cct eukaryotic chaperonin subunits of
Saccharomyces cerevisiae and other yeasts, Yeast 12, 523-529.
Yokota, S., Yanagi, H., Yura, T., and Kubota, H. (1999) Cytosolic chaperonin
is up-regulated during cell growth. Preferential expression and binding to
tubulin at G(1)/S transition through early S phase, J Biol Chem 274, 3707037078.
Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H.,
Gamblin, S. J., Smerdon, S. J., and Cantley, L. C. (1997) The structural basis
for 14-3-3:phosphopeptide binding specificity, Cell 91, 961-971.
Willardson, B. M., and Howlett, A. C. (2007) Function of phosducin-like
proteins in G protein signaling and chaperone-assisted protein folding, Cell
Signal.
Gygi, S. (2008) Personal communication between Barry M. Willardson and
Steven Gygi, (Willardson, B. M., Ed.).
Nakano, K., Chen, J., Tarr, G. E., Yoshida, T., Flynn, J. M., and Bitensky, M.
W. (2001) Rethinking the role of phosducin: light-regulated binding of
phosducin to 14-3-3 in rod inner segments, Proc Natl Acad Sci U S A 98,
4693-4698.
95

110.

111.
112.

113.
114.
115.
116.
117.

Thulin, C. D., Savage, J. R., McLaughlin, J. N., Truscott, S. M., Old, W. M.,
Ahn, N. G., Resing, K. A., Hamm, H. E., Bitensky, M. W., and Willardson, B.
M. (2001) Modulation of the G protein regulator phosducin by
Ca2+/calmodulin-dependent protein kinase II phosphorylation and 14-3-3
protein binding, J Biol Chem 276, 23805-23815.
Yu, L., Pena Castillo, L., Mnaimneh, S., Hughes, T. R., and Brown, G. W.
(2006) A survey of essential gene function in the yeast cell division cycle, Mol
Biol Cell 17, 4736-4747.
Siegers, K., Waldmann, T., Leroux, M. R., Grein, K., Shevchenko, A.,
Schiebel, E., and Hartl, F. U. (1999) Compartmentation of protein folding in
vivo: sequestration of non-native polypeptide by the chaperonin-GimC
system, EMBO J 18, 75-84.
Bridges, D., and Moorhead, G. B. (2004) 14-3-3 proteins: a number of
functions for a numbered protein, Sci STKE 2004, re10.
Mackintosh, C. (2004) Dynamic interactions between 14-3-3 proteins and
phosphoproteins regulate diverse cellular processes, Biochem J 381, 329-342.
Noble, C. G., and Song, H. (2008) Structural studies of elongation and release
factors, Cell Mol Life Sci 65, 1335-1346.
Nelson, D. L., and Cox, M. M., (Eds.) (2000) Lehninger Principles of
Biochemistry, 3 ed., Worth Publishers, New York, New York.
Meskauskas, A., and Dinman, J. D. (2008) Ribosomal protein L3 functions as
a 'rocker switch' to aid in coordinating of large subunit-associated functions in
eukaryotes and Archaea, Nucleic Acids Res 36, 6175-6186.

96

